1 00:00:05,056 --> 00:00:07,492 GOOD AFTERNOON, EVERYONE. 2 00:00:07,492 --> 00:00:10,461 I'M CALLING THE MEETING TO 3 00:00:10,461 --> 00:00:10,761 ORDER. 4 00:00:10,761 --> 00:00:13,865 I'M DR. GERRY PARKER FOR BIO 5 00:00:13,865 --> 00:00:15,032 SECURITY AND I'D LIKE TO CALL 6 00:00:15,032 --> 00:00:16,334 THE VIRTUAL MEETING TO ORDER. 7 00:00:16,334 --> 00:00:19,237 THANK YOU FOR BEING HERE TODAY. 8 00:00:19,237 --> 00:00:22,673 I WOULD FIRST LIKE TO WELCOME 9 00:00:22,673 --> 00:00:26,177 OTHER MEMBERS OF THE NSABB, OUR 10 00:00:26,177 --> 00:00:26,811 FEDERAL COLLEAGUES AND AGENCY 11 00:00:26,811 --> 00:00:29,847 AND MEMBERS OF THE PUBLIC 12 00:00:29,847 --> 00:00:31,415 JOINING ON WEBCAST TODAY. 13 00:00:31,415 --> 00:00:33,885 AS THOSE OF YOU PARTICIPATING 14 00:00:33,885 --> 00:00:37,989 KNOW, THE NSABB IS A FEDERAL 15 00:00:37,989 --> 00:00:40,191 ADVISORY COMMITTEE THAT PROVIDES 16 00:00:40,191 --> 00:00:43,394 REQUESTED ADVICE, GUIDANCE AND 17 00:00:43,394 --> 00:00:44,729 RECOMMENDATIONS TO THE 18 00:00:44,729 --> 00:00:46,631 U.S. GOVERNMENT ON BIO SECURITY 19 00:00:46,631 --> 00:00:47,932 AND LIFE SCIENCE RESEARCH 20 00:00:47,932 --> 00:00:48,199 CONCERNS. 21 00:00:48,199 --> 00:00:52,036 BEFORE I MAKE ADDITIONAL 22 00:00:52,036 --> 00:00:54,705 REMARKS, I'D LIKE TO TURN THE 23 00:00:54,705 --> 00:00:58,242 AGENDA OVER TO CARI YOUNG THE 24 00:00:58,242 --> 00:01:00,011 DESIGNATED FEDERAL OFFICER OF 25 00:01:00,011 --> 00:01:03,581 NSABB TO REVIEW THE POLICY AND 26 00:01:03,581 --> 00:01:04,916 PROVIDE ADDITIONAL REMINDERS. 27 00:01:04,916 --> 00:01:05,550 CARI. 28 00:01:05,550 --> 00:01:06,517 >> THANK YOU, I'LL BRIEFLY 29 00:01:06,517 --> 00:01:08,085 DESCRIBE THE RULES OF CONDUCT 30 00:01:08,085 --> 00:01:09,720 AND CONFLICT OF INTEREST 31 00:01:09,720 --> 00:01:10,855 STATEMENT FOR THE NSABB. 32 00:01:10,855 --> 00:01:13,257 AS A MEMBER OF THIS COMMITTEE 33 00:01:13,257 --> 00:01:14,759 YOU'RE A SPECIAL GOVERNMENT 34 00:01:14,759 --> 00:01:15,693 EMPLOYEE AND THEREFORE SUBJECT 35 00:01:15,693 --> 00:01:18,062 TO RULES OF CONDUCT THAT APPLY 36 00:01:18,062 --> 00:01:19,030 TO GOVERNMENT EMPLOYEES. 37 00:01:19,030 --> 00:01:21,198 THE RULES AND REGULATIONS ARE 38 00:01:21,198 --> 00:01:23,634 EXPLAINED IN A REPORT TITLED 39 00:01:23,634 --> 00:01:26,837 STANDARDS OF ONLY OF ETHICAL 40 00:01:26,837 --> 00:01:28,539 CONDUCT FOR EMPLOYEES OF THE 41 00:01:28,539 --> 00:01:29,507 EXECUTIVE BRANCH. 42 00:01:29,507 --> 00:01:30,708 YOU RECEIVE THE WHEN APPOINTED 43 00:01:30,708 --> 00:01:31,442 TO THE COMMITTEE. 44 00:01:31,442 --> 00:01:32,944 IN ADDITION TO REMINDING YOU 45 00:01:32,944 --> 00:01:34,245 ABOUT THE IMPORTANCE OF 46 00:01:34,245 --> 00:01:35,313 FOLLOWING THE ETHICS RULES, WE 47 00:01:35,313 --> 00:01:37,181 ALWAYS LIKE TO REVIEW THE STEPS 48 00:01:37,181 --> 00:01:40,284 WE TAKE AND ASK YOU TO TAKE TO 49 00:01:40,284 --> 00:01:42,386 ENSURE THAT ANY CONFLICTS OF 50 00:01:42,386 --> 00:01:43,487 INTEREST ARE ADDRESSED. 51 00:01:43,487 --> 00:01:45,456 AS YOU KNOW, AT SCHEDULED 52 00:01:45,456 --> 00:01:47,258 INTERVIEWS YOU PROVIDE US WITH 53 00:01:47,258 --> 00:01:49,226 INFORMATION ABOUT YOUR PERSONAL, 54 00:01:49,226 --> 00:01:50,328 PROFESSIONAL AND FINANCIAL 55 00:01:50,328 --> 00:01:50,595 INTERESTS. 56 00:01:50,595 --> 00:01:52,363 WE USE THIS INFORMATION AS THE 57 00:01:52,363 --> 00:01:54,065 BASIS FOR ASSESSING WHETHER YOU 58 00:01:54,065 --> 00:01:57,435 HAVE ANY REAL, POTENTIAL OR 59 00:01:57,435 --> 00:01:58,235 APPARENT CONFLICTS OF INTEREST 60 00:01:58,235 --> 00:01:59,837 THAT COULD COMPROMISE YOUR 61 00:01:59,837 --> 00:02:01,172 ABILITY TO BE OBJECTIVE IN 62 00:02:01,172 --> 00:02:03,007 GIVING ADVICE DURING COMMITTEE 63 00:02:03,007 --> 00:02:03,274 MEETINGS. 64 00:02:03,274 --> 00:02:04,609 WHILE WE WAIVE CONFLICTS OF 65 00:02:04,609 --> 00:02:06,644 INTEREST FOR GENERAL MATTERS 66 00:02:06,644 --> 00:02:08,312 BECAUSE WE BELIEVE YOUR ABILITY 67 00:02:08,312 --> 00:02:11,849 TO BE OBJECTIVE WILL NOT BE 68 00:02:11,849 --> 00:02:13,250 AFFECTED BY YOUR INTERESTS WE 69 00:02:13,250 --> 00:02:21,192 RELY ON YOU TO BE ATTENTIVE TO 70 00:02:21,192 --> 00:02:24,161 OF A POSSIBLE INTEREST AFFECTING 71 00:02:24,161 --> 00:02:26,631 YOUR INTEREST AND ASK YOU TO 72 00:02:26,631 --> 00:02:27,832 RECUSE YOURSELF AND LEAVE THE 73 00:02:27,832 --> 00:02:28,265 ZOOM MEETING. 74 00:02:28,265 --> 00:02:29,533 IF YOU HAVE ANY QUESTIONS ABOUT 75 00:02:29,533 --> 00:02:32,570 RULES OF CONDUCT OR CONFLICT OF 76 00:02:32,570 --> 00:02:34,271 INTEREST, OUR COMMITTEE 77 00:02:34,271 --> 00:02:37,742 MANAGEMENT OFFICER, SONYA 78 00:02:37,742 --> 00:02:42,847 FREEMAN WILL BE TRHAPPY TO ADDRS 79 00:02:42,847 --> 00:02:43,047 THEM. 80 00:02:43,047 --> 00:02:47,151 KEEP YOUR MIKES MUTED WHEN NOT 81 00:02:47,151 --> 00:02:50,621 SPEAKING BEING AND TURN YOUR 82 00:02:50,621 --> 00:02:52,123 CAMERAS ON WHEN SPEAKING AND USE 83 00:02:52,123 --> 00:02:54,091 THE RAISED HAND FUNCTION IN ZOOM 84 00:02:54,091 --> 00:02:55,459 AND USE THAT TO INDICATE YOUR 85 00:02:55,459 --> 00:02:56,694 INTEREST IN JOINING THE 86 00:02:56,694 --> 00:02:58,295 DISCUSSION AND DR. PARKER, I'LL 87 00:02:58,295 --> 00:02:59,263 TURN IT OVER TO YOU. 88 00:02:59,263 --> 00:03:00,498 >> THANK YOU, CARI. 89 00:03:00,498 --> 00:03:02,667 BEFORE WE GET INTO THE MEAT OF 90 00:03:02,667 --> 00:03:03,968 THE MEETING A FEW THINGS I WANT 91 00:03:03,968 --> 00:03:05,236 TO SPEAK ABOUT AND ANNOUNCE. 92 00:03:05,236 --> 00:03:07,271 FIRST I'D LIKE IT TAKE THE 93 00:03:07,271 --> 00:03:08,739 OPPORTUNITY TO THANK THOSE NSABB 94 00:03:08,739 --> 00:03:11,509 MEMBERS WHO HAVE COMPLETED THE 95 00:03:11,509 --> 00:03:13,277 TERMS OF SERVICE SINCE THE BOARD 96 00:03:13,277 --> 00:03:18,416 LAST MET AND SPECIFICALLY 97 00:03:18,416 --> 00:03:21,652 DOCTORS PAMELA SILVER AND 98 00:03:21,652 --> 00:03:23,554 DR. EAGAN PROVIDING EXPERTISE 99 00:03:23,554 --> 00:03:25,623 AND THOUGHTFUL INPUT AS MEMBERS 100 00:03:25,623 --> 00:03:27,792 AND I'D LIKE TO THANK THEM FOR 101 00:03:27,792 --> 00:03:29,927 THEIR DEDICATED SERVICE. 102 00:03:29,927 --> 00:03:32,163 I WOULD ALSO LIKE TO EXTEND A 103 00:03:32,163 --> 00:03:36,133 WARM WELCOME TO THE INCOMING 104 00:03:36,133 --> 00:03:41,305 VOTING MEMBERS AND SEVERAL 105 00:03:41,305 --> 00:03:42,907 EX-OFFICIO MEMBERS JOINING FROM 106 00:03:42,907 --> 00:03:43,708 ACROSS THE GOVERNMENT. 107 00:03:43,708 --> 00:03:46,911 I'M GLAD AND ESPECIALLY PLEASED 108 00:03:46,911 --> 00:03:50,848 TO SEE SO MANY WHY YOU 109 00:03:50,848 --> 00:03:51,682 EX-OFFICIOS JOINING. 110 00:03:51,682 --> 00:03:55,319 YOUR INPUT WILL BE INVALUABLE TO 111 00:03:55,319 --> 00:03:57,121 THE BOARD GOING FORWARD. 112 00:03:57,121 --> 00:03:59,657 THANK YOU FOR YOUR WILLINGNESS 113 00:03:59,657 --> 00:04:03,928 TO SERVE AND SUPPORT THE NSABB 114 00:04:03,928 --> 00:04:05,296 FOR IMPORTANT INFORMATION YOU'LL 115 00:04:05,296 --> 00:04:07,631 BRING ACROSS THE AGENCY. 116 00:04:07,631 --> 00:04:09,333 LASTLY, I'D LIKE TO ANNOUNCE MY 117 00:04:09,333 --> 00:04:10,701 TERM OF SERVICE WOULD BE SERVING 118 00:04:10,701 --> 00:04:14,505 AS A MEMBER AND CHAIR OF THE 119 00:04:14,505 --> 00:04:15,973 NSABB WILL COME TO AN END AT THE 120 00:04:15,973 --> 00:04:17,174 END OF THE MONTH. 121 00:04:17,174 --> 00:04:18,776 THIS IS MY LAST MEETING. 122 00:04:18,776 --> 00:04:20,478 I WANT TO SAY IT'S BEEN AN HONOR 123 00:04:20,478 --> 00:04:23,380 TO SERVE WITH ALL THE NSABB 124 00:04:23,380 --> 00:04:24,882 BOARD MEMBERS AND CURRENT 125 00:04:24,882 --> 00:04:28,319 MEMBERS THAT CULMINATED IN OUR 126 00:04:28,319 --> 00:04:29,286 2023 NSABB REPORT. 127 00:04:29,286 --> 00:04:32,389 I KNOW THAT REPORT WAS WELL 128 00:04:32,389 --> 00:04:34,391 RECEIVED IN MANY CIRCLES SO 129 00:04:34,391 --> 00:04:36,060 THANK YOU FOR YOUR DEDICATION. 130 00:04:36,060 --> 00:04:38,629 IT'S BEEN AN HONOR TO SERVE WITH 131 00:04:38,629 --> 00:04:39,130 ALL OF YOU. 132 00:04:39,130 --> 00:04:41,265 I WANT TO SAY A SPECIAL THANKS 133 00:04:41,265 --> 00:04:44,802 TO CARI, KEVIN AND OTHER MEMBERS 134 00:04:44,802 --> 00:04:47,905 OF THE STAFF WHO PROVIDED US 135 00:04:47,905 --> 00:04:49,073 OUTSTANDING SUPPORT THROUGH OUR 136 00:04:49,073 --> 00:04:49,473 DELIBERATIONS. 137 00:04:49,473 --> 00:04:50,641 WE COULDN'T HAVE DONE THE WORK 138 00:04:50,641 --> 00:04:52,843 AND PRODUCED THE REPORT WE DID 139 00:04:52,843 --> 00:04:55,513 SO WELL RECEIVED WITHOUT THEIR 140 00:04:55,513 --> 00:04:58,249 TIRELESS WORK BEHIND THE SCENES 141 00:04:58,249 --> 00:05:00,684 IN SUPPORT OF US. 142 00:05:00,684 --> 00:05:05,156 SO WITH THAT DONE, I AM 143 00:05:05,156 --> 00:05:07,124 ESPECIALLY PLEASED RACHEL 144 00:05:07,124 --> 00:05:08,559 LEVINSON WILL TAKE OVER STARTING 145 00:05:08,559 --> 00:05:10,427 NEXT MONTH OF NSABB. 146 00:05:10,427 --> 00:05:12,630 WE'VE HAD THE PLEASURE OF BEING 147 00:05:12,630 --> 00:05:14,331 COLLEAGUES MANY YEARS INCLUDING 148 00:05:14,331 --> 00:05:15,833 WORKING ON NSABB AND OTHER 149 00:05:15,833 --> 00:05:17,768 RELATED ACTIVITIES. 150 00:05:17,768 --> 00:05:19,637 I'M CONFIDENT SHE WILL BE A 151 00:05:19,637 --> 00:05:21,806 STRONG AND EFFECTIVE LEADER TO 152 00:05:21,806 --> 00:05:25,342 NSABB AND YOU WILL BENEFIT FROM 153 00:05:25,342 --> 00:05:27,211 HER EXPERTISE AND LEADERSHIP. 154 00:05:27,211 --> 00:05:27,878 YOU'RE IN GOOD HANDS WITH 155 00:05:27,878 --> 00:05:31,615 RACHEL. 156 00:05:31,615 --> 00:05:33,784 AND NOW AS WE BEGIN TO GET INTO 157 00:05:33,784 --> 00:05:34,952 THE MEAT OF THE MEETING WE'RE 158 00:05:34,952 --> 00:05:36,086 FORTUNATE TO BE JOINED BY 159 00:05:36,086 --> 00:05:37,021 REPRESENTATIVES FROM THE 160 00:05:37,021 --> 00:05:37,988 EXECUTIVE OFFICE OF THE 161 00:05:37,988 --> 00:05:39,356 PRESIDENT AND DEPARTMENT OF 162 00:05:39,356 --> 00:05:42,626 HEALTH AND HUMAN SERVICES TO 163 00:05:42,626 --> 00:05:44,695 PROVIDER OPENING REMARKS AND 164 00:05:44,695 --> 00:05:45,596 CONTEXT FOR THE WORK THE 165 00:05:45,596 --> 00:05:47,231 COMMITTEE WILL BE TAKING ON 166 00:05:47,231 --> 00:05:47,898 AFTER THIS MEETING. 167 00:05:47,898 --> 00:05:50,568 SO TO GET US STARTED, I WOULD 168 00:05:50,568 --> 00:05:54,071 LIKE TO WELCOME DR. SANDROM THE 169 00:05:54,071 --> 00:05:55,439 SPECIAL ASSISTANT TO THE 170 00:05:55,439 --> 00:05:57,174 PRESIDENT AND SENIOR DIRECTOR OF 171 00:05:57,174 --> 00:06:00,077 GLOBAL HEALTH SECURITY AND BIO 172 00:06:00,077 --> 00:06:04,381 DEFENSE AT THE NATIONAL SECURITY 173 00:06:04,381 --> 00:06:04,949 COUNCIL. 174 00:06:04,949 --> 00:06:06,617 HE SERVED AS THE DIRECTOR FOR 175 00:06:06,617 --> 00:06:08,519 THE CENTER FOR BIO ENGINEERING 176 00:06:08,519 --> 00:06:10,120 AT THE NATIONAL LABORATORY WHERE 177 00:06:10,120 --> 00:06:12,122 HE LED THE LAB'S BIO 178 00:06:12,122 --> 00:06:12,723 ENGINEERING, STRATEGY AND 179 00:06:12,723 --> 00:06:14,491 TECHNOLOGY DEVELOPMENT 180 00:06:14,491 --> 00:06:16,861 ACTIVITIES TO ADDRESS CRITICAL 181 00:06:16,861 --> 00:06:18,229 CHALLENGES IN HEALTH AND BIO 182 00:06:18,229 --> 00:06:18,562 SECURITY. 183 00:06:18,562 --> 00:06:20,097 HE ALSO HAS EXPERIENCE IN THE 184 00:06:20,097 --> 00:06:21,699 PRIVATE SECTOR LEADING EFFORTS 185 00:06:21,699 --> 00:06:23,500 TO DEVELOP MODELLING AND 186 00:06:23,500 --> 00:06:24,869 SOFTWARE FOR PHYSIOLOGY AND 187 00:06:24,869 --> 00:06:25,236 BIOLOGY. 188 00:06:25,236 --> 00:06:26,804 HIS EXTENSIVE AND VARIED 189 00:06:26,804 --> 00:06:29,440 EXPERIENCES BRING A WEALTH OF 190 00:06:29,440 --> 00:06:30,975 EXPERTISE AND WE LOOK FORWARD TO 191 00:06:30,975 --> 00:06:32,076 HIS INSIGHT. 192 00:06:32,076 --> 00:06:37,114 IT'S MY HONOR TO HAND THE 193 00:06:37,114 --> 00:06:37,848 DISCUSSION OVER HIM. 194 00:06:37,848 --> 00:06:39,950 >> I APPRECIATE IT. 195 00:06:39,950 --> 00:06:42,119 THANK YOU ALL FOR JOINING AND TO 196 00:06:42,119 --> 00:06:46,657 OUR COLLEAGUES OVER IN HHS FOR 197 00:06:46,657 --> 00:06:47,725 SUPPORTING THIS PARTICULAR 198 00:06:47,725 --> 00:06:48,792 ENDEAVOR AND KICKING THIS 199 00:06:48,792 --> 00:06:49,159 MEETING OFF. 200 00:06:49,159 --> 00:06:51,629 AT THE OUTSET I WANT TO CONVEY 201 00:06:51,629 --> 00:06:54,498 MY PERSONAL THANKS AND GRATITUDE 202 00:06:54,498 --> 00:07:00,604 TO THIS COMBHT COMMITTEE TO HE 203 00:07:00,604 --> 00:07:02,172 FINALIZE THE GOVERNMENT 204 00:07:02,172 --> 00:07:04,441 OVERSIGHT OF DUAL USE AND 205 00:07:04,441 --> 00:07:06,343 PATHOGENS WITH ENHANCED PANDEMIC 206 00:07:06,343 --> 00:07:06,977 POTENTIAL. 207 00:07:06,977 --> 00:07:10,748 THE WORK FROM NSABB AND ITS 208 00:07:10,748 --> 00:07:12,182 THOUGHTFUL RECOMMENDATIONS 209 00:07:12,182 --> 00:07:13,550 DIRECTLY INFORMED THIS EFFORT TO 210 00:07:13,550 --> 00:07:18,322 HELP UNIFY, STREAMLINE, EXPAND 211 00:07:18,322 --> 00:07:20,958 AND STRENGTHEN THE DUAL USE OF 212 00:07:20,958 --> 00:07:21,625 RESEARCH OF CONCERN. 213 00:07:21,625 --> 00:07:25,162 THAT RECOGNIZES THE BENEFITS AND 214 00:07:25,162 --> 00:07:26,864 RISKS ASSOCIATED WITH RESEARCH 215 00:07:26,864 --> 00:07:29,767 ON PATHOGENS AND TOXIN. 216 00:07:29,767 --> 00:07:34,705 THEY'RE CRITICAL TO STRENGTHEN 217 00:07:34,705 --> 00:07:37,708 OUR BIO DIVERSE AND CALLED OUT 218 00:07:37,708 --> 00:07:39,243 IN OUR STRATEGY AND CREATE 219 00:07:39,243 --> 00:07:39,510 OVERSIGHT. 220 00:07:39,510 --> 00:07:41,345 THE POLICY ALSO ACKNOWLEDGES THE 221 00:07:41,345 --> 00:07:44,648 RAPIDLY EVOLVING NATURE OF 222 00:07:44,648 --> 00:07:46,250 COMPUTATIONAL BIOLOGY AND 223 00:07:46,250 --> 00:07:49,053 INCREASING USE OF INSILICO 224 00:07:49,053 --> 00:07:51,422 MODELS AND DATA SETS INCLUDING 225 00:07:51,422 --> 00:07:54,024 ARTIFICIAL INTELLIGENCE METHODS 226 00:07:54,024 --> 00:07:55,693 AND APPROACHES TO BRING BIOLOGY 227 00:07:55,693 --> 00:08:00,064 KNOWLEDGE, INFORMATION, 228 00:08:00,064 --> 00:08:02,466 TECHNOLOGIES AND PRODUCTS. 229 00:08:02,466 --> 00:08:04,234 BUT WHILE THE POLICY HAS 230 00:08:04,234 --> 00:08:10,641 OVERSIGHT OF THE COMPUTATIONAL 231 00:08:10,641 --> 00:08:13,744 TECHNOLOGIES AND DATA SET DOES 232 00:08:13,744 --> 00:08:16,013 NOT HAVE CONSISTENT DATA 233 00:08:16,013 --> 00:08:19,416 RESEARCH AND IN SILICO MODELS 234 00:08:19,416 --> 00:08:21,485 CAN CREATE AN INFORMATION HAZARD 235 00:08:21,485 --> 00:08:24,655 OR PROVIDE THE CAPABILITY TO 236 00:08:24,655 --> 00:08:28,359 ENABLE MALACTORS AND ADVERSARIES 237 00:08:28,359 --> 00:08:30,961 TO EVADE OUR PREPAREDNESS AND 238 00:08:30,961 --> 00:08:31,662 CAUSE HARM. 239 00:08:31,662 --> 00:08:33,330 AT THE SAME TIME WE UNDERSTAND 240 00:08:33,330 --> 00:08:36,033 THE IN SILICO APPROACHES ARE 241 00:08:36,033 --> 00:08:37,701 CRITICAL TO OUR MITIGATION 242 00:08:37,701 --> 00:08:41,505 STRATEGY TO REDUCE THREATS FROM 243 00:08:41,505 --> 00:08:42,439 BIOLOGICAL INCIDENTS. 244 00:08:42,439 --> 00:08:46,543 FOR INSTANCE, OF COURSE IN 245 00:08:46,543 --> 00:08:48,078 SILICO APPROACHES OFFER I SAFER 246 00:08:48,078 --> 00:08:50,614 WAY TO STUDY BIOLOGY WITHOUT 247 00:08:50,614 --> 00:08:51,815 EXPERIMENTATION AND THE 248 00:08:51,815 --> 00:08:52,750 POTENTIAL RISK FROM ACCIDENTS. 249 00:08:52,750 --> 00:08:55,719 THEY'RE CRITICAL TO HELPING 250 00:08:55,719 --> 00:08:58,322 DEVELOP MORE RAPIDLY MORE 251 00:08:58,322 --> 00:09:00,557 EFFECTIVE COUNTER MEASURES 252 00:09:00,557 --> 00:09:02,993 AGAINST EVOLVING BIO THREATS. 253 00:09:02,993 --> 00:09:05,329 REALIZING THE ENORMOUS PROMISE 254 00:09:05,329 --> 00:09:10,067 OF THESE TECHNOLOGIES, AND UNDER 255 00:09:10,067 --> 00:09:10,701 SCORING OUR EFFORTS FOR 256 00:09:10,701 --> 00:09:13,871 LEADERSHIP IS A KEY PRIORITY OF 257 00:09:13,871 --> 00:09:14,872 THIS ADMINISTRATION. 258 00:09:14,872 --> 00:09:16,974 AS SUCH WE ARE REQUESTING THE 259 00:09:16,974 --> 00:09:19,176 NSABB PERFORM A DETAILED REVIEW 260 00:09:19,176 --> 00:09:21,945 AND PROVIDE RECOMMENDATIONS ON 261 00:09:21,945 --> 00:09:23,313 HOW TO BEST IDENTIFY, 262 00:09:23,313 --> 00:09:25,649 PRIORITIZE, PREVENT AND MITIGATE 263 00:09:25,649 --> 00:09:29,953 RISKS FROM MISUSE OF INSILICO, 264 00:09:29,953 --> 00:09:34,391 RESEARCH, MODELS, TOOLS AN DATA 265 00:09:34,391 --> 00:09:34,758 SETS. 266 00:09:34,758 --> 00:09:36,393 WE HOPE THIS COMMITTEE WILL 267 00:09:36,393 --> 00:09:38,362 CONSIDER WAYS IN WHICH INSILICO 268 00:09:38,362 --> 00:09:42,099 RESEARCH ONLY PATHOGENS AND 269 00:09:42,099 --> 00:09:43,267 TOXINS COULD CREATE INFORMATION 270 00:09:43,267 --> 00:09:45,202 HAZARDS THAT COULD BE EXPLOITED 271 00:09:45,202 --> 00:09:50,541 BY NEFARIOUS ACTORS OR CREATE 272 00:09:50,541 --> 00:09:52,976 NEW BIO WEAPONS. 273 00:09:52,976 --> 00:09:56,814 WE HOPE TO HAVE A SECURITY 274 00:09:56,814 --> 00:09:59,216 INFORMED SET OF RECOMMENDATIONS 275 00:09:59,216 --> 00:10:00,651 ON FUTURE POLICY INCLUDING 276 00:10:00,651 --> 00:10:03,120 SPECIFIC REVIEW CRITERIA, 277 00:10:03,120 --> 00:10:04,388 GUIDELINES AND BEST PRACTICES 278 00:10:04,388 --> 00:10:06,623 FOR RESEARCHERS AND SUGGESTIONS 279 00:10:06,623 --> 00:10:08,625 FOR SEQUENCEFUL ORIENTATION. 280 00:10:08,625 --> 00:10:10,627 ONCE AGAIN THANK YOU FOR 281 00:10:10,627 --> 00:10:11,628 UNDERTAKING THIS CRITICAL EFFORT 282 00:10:11,628 --> 00:10:13,363 AND WE LOOK FORWARD TO READING 283 00:10:13,363 --> 00:10:13,664 YOUR REPORT. 284 00:10:13,664 --> 00:10:18,469 THANK YOU. 285 00:10:18,469 --> 00:10:20,604 >> THANK YOU FOR YOUR ENGAGING 286 00:10:20,604 --> 00:10:22,206 AND THOUGHT PROVOKING REMARKS AS 287 00:10:22,206 --> 00:10:24,475 THE BOARD BEGINS TO TAKE ON THIS 288 00:10:24,475 --> 00:10:28,312 NEW TASK THAT WE'LL GET IN A FEW 289 00:10:28,312 --> 00:10:30,881 MINUTES. 290 00:10:30,881 --> 00:10:33,617 FIRST, NEXT WELCOME PLEASED TO 291 00:10:33,617 --> 00:10:36,453 WELCOME DR. SOMA AS THE 292 00:10:36,453 --> 00:10:37,721 ASSISTANT DIRECTOR FOR 293 00:10:37,721 --> 00:10:39,056 ARTIFICIAL INTELLIGENCE AND BIO 294 00:10:39,056 --> 00:10:40,124 SECURITY IN THE WHITE HOUSE 295 00:10:40,124 --> 00:10:42,126 OFFICE OF SCIENCE AND TECHNOLOGY 296 00:10:42,126 --> 00:10:42,626 POLICY. 297 00:10:42,626 --> 00:10:45,629 BEFORE JOINING OSTP HE WAS 298 00:10:45,629 --> 00:10:47,931 PROGRAM MANAGER AT DARPA WHERE 299 00:10:47,931 --> 00:10:51,034 HE EVERY SAW RESEARCH IN BIO 300 00:10:51,034 --> 00:10:52,870 ELECTRONICS, BRAIN COMPUTER 301 00:10:52,870 --> 00:10:54,071 INTERFACES AND BIO SECURITY. 302 00:10:54,071 --> 00:10:56,673 PRIOR TO THAT WORK HE WAS A 303 00:10:56,673 --> 00:11:07,217 PHYSICIAN SCIENTIST AT THE BROD 304 00:11:08,218 --> 00:11:11,788 INSTITUTE AND HARVARD AND HE 305 00:11:11,788 --> 00:11:13,657 WILL PROVIDE PERSPECTIVE TO THE 306 00:11:13,657 --> 00:11:13,857 BOARD. 307 00:11:13,857 --> 00:11:16,760 PLEASE GO AHEAD. 308 00:11:16,760 --> 00:11:19,930 >> THANK YOU SO MUCH FOR THE 309 00:11:19,930 --> 00:11:20,264 INTRODUCTION. 310 00:11:20,264 --> 00:11:23,000 THANK YOU FOR JOINING TODAY. 311 00:11:23,000 --> 00:11:26,503 I'LL KEEP MY REMARKS BRIEF TO 312 00:11:26,503 --> 00:11:27,337 MOVE TO DO DISCUSSION. 313 00:11:27,337 --> 00:11:28,705 FIRST I'D LIKE TO ACKNOWLEDGE 314 00:11:28,705 --> 00:11:30,707 HHS AND KICKING THIS OFF. 315 00:11:30,707 --> 00:11:35,712 ON BEHALF OF THE OSTP I'D LIKE 316 00:11:35,712 --> 00:11:39,950 TO REITERATE WE'RE LOOKING AT 317 00:11:39,950 --> 00:11:41,218 THE ACCIDENTAL AND BIO THREATS 318 00:11:41,218 --> 00:11:43,687 AND GRATEFUL FOR THE 319 00:11:43,687 --> 00:11:44,688 RECOMMENDATIONS THE NSABB 320 00:11:44,688 --> 00:11:47,724 PROVIDED THAT SHAPED THE 321 00:11:47,724 --> 00:11:49,193 DUAL-USE RESEARCH POLICY AND 322 00:11:49,193 --> 00:11:50,627 EAGER TO SEE CONTINUED 323 00:11:50,627 --> 00:11:52,129 ENGAGEMENT SO WE CAN BETTER 324 00:11:52,129 --> 00:11:54,498 UNDERSTAND HOW TO EXTEND THIS 325 00:11:54,498 --> 00:11:58,135 POLICY TO THE IN SILICO REGIME 326 00:11:58,135 --> 00:11:59,703 DUE TO THE VARIETY OF REASONS 327 00:11:59,703 --> 00:12:01,238 HIGHLIGHTED. 328 00:12:01,238 --> 00:12:02,706 I WANT TO THANK YOU AGAIN AND 329 00:12:02,706 --> 00:12:06,143 VERY MUCH LOOK FORWARD TO 330 00:12:06,143 --> 00:12:08,378 READING YOUR REPORT. 331 00:12:08,378 --> 00:12:10,047 >> THANK YOU, DR. SARMA. 332 00:12:10,047 --> 00:12:13,817 NOW I'D LIKE TO WELCOME MS. ELAY 333 00:12:13,817 --> 00:12:15,118 FLA BUSH THE DEPUTY SECRETARY 334 00:12:15,118 --> 00:12:17,988 FOR THE OFFICE OF THE ASSISTANT 335 00:12:17,988 --> 00:12:20,857 SECRETARY FOR PLANNING AND 336 00:12:20,857 --> 00:12:23,193 EVALUATION AT HHS AND BRINGS 30 337 00:12:23,193 --> 00:12:26,563 YEARS OF EXPERIENCE WORKING FOR 338 00:12:26,563 --> 00:12:31,868 THE DEPARTMENT OF HHSED AND HAS 339 00:12:31,868 --> 00:12:33,904 EXPERTISE IN POLICY DEVELOPMENT, 340 00:12:33,904 --> 00:12:35,305 ANALYSIS AND EVALUATION AND 341 00:12:35,305 --> 00:12:36,673 PLANNING RELATED TO SCIENCE AND 342 00:12:36,673 --> 00:12:40,544 DATA POLICY ISSUES AND BRINGS 343 00:12:40,544 --> 00:12:44,214 UNIQUE PERSPECTIVE FOR THE DATA 344 00:12:44,214 --> 00:12:45,949 DRIVEN AND SCIENTIFICALLY 345 00:12:45,949 --> 00:12:47,050 INFORMED APPROACH. 346 00:12:47,050 --> 00:12:49,553 MS. BUSH, THE FLOOR IS YOURS. 347 00:12:49,553 --> 00:12:51,922 >> THANK YOU FOR THE KIND 348 00:12:51,922 --> 00:12:55,959 INTRODUCTION AND ON BEHALF OF 349 00:12:55,959 --> 00:12:58,462 THE DEPARTMENT OF HEALTH AND 350 00:12:58,462 --> 00:12:59,596 HUMAN SERVICE THANK YOU FOR THIS 351 00:12:59,596 --> 00:13:00,931 YOUR SERVICE ON THIS FEDERAL 352 00:13:00,931 --> 00:13:04,201 ADVISORY COMMITTEE AND I'D LIKE 353 00:13:04,201 --> 00:13:06,136 TO THANK MY NIH COLLEAGUES FOR 354 00:13:06,136 --> 00:13:07,437 THEIR MANAGEMENT OF THE 355 00:13:07,437 --> 00:13:08,872 COMMITTEE AND HOSTING THE 356 00:13:08,872 --> 00:13:10,374 MEETING AND THE OFFICES OF 357 00:13:10,374 --> 00:13:11,275 SCIENCE AND TECHNOLOGY POLICY 358 00:13:11,275 --> 00:13:13,377 FOR THEIR OPENING REMARKS. 359 00:13:13,377 --> 00:13:14,511 IN COORDINATION WITH 360 00:13:14,511 --> 00:13:16,446 U.S. GOVERNMENT PARTNERS, HHS IS 361 00:13:16,446 --> 00:13:18,915 COMMITTED TO ENABLING CRITICAL 362 00:13:18,915 --> 00:13:21,151 LIFE SAVING ADVANCES IN SCIENCE 363 00:13:21,151 --> 00:13:22,619 AND TECHNOLOGY WHILE 364 00:13:22,619 --> 00:13:24,154 APPROPRIATELY MITIGATING RISKS. 365 00:13:24,154 --> 00:13:26,690 SOME OF THE CRITICAL RESEARCH 366 00:13:26,690 --> 00:13:29,192 THAT HHS SUPPORTS HELPS US 367 00:13:29,192 --> 00:13:34,398 UNDERSTAND THE NATURE OF 368 00:13:34,398 --> 00:13:35,766 PATHOGENS AND EFFORTS THROUGH 369 00:13:35,766 --> 00:13:37,834 DEVELOPMENT OF VACCINES AND 370 00:13:37,834 --> 00:13:39,770 OTHER MEDICAL COUNTER MEASURES. 371 00:13:39,770 --> 00:13:42,372 I'M PROUD TO SAY HHS HOUSES AND 372 00:13:42,372 --> 00:13:44,374 FUNDS THE WORLD'S LEADING 373 00:13:44,374 --> 00:13:52,316 EXPERTS ON TOPICS FROM SYNTHETIC 374 00:13:52,316 --> 00:13:54,985 BIOLOGY AND DEVELOPMENTS AND 375 00:13:54,985 --> 00:13:55,952 SAFETY EFFORTS AND MANY EXPERTS 376 00:13:55,952 --> 00:13:56,720 IN THE MEETING NOW. 377 00:13:56,720 --> 00:13:59,022 WE'RE LIVING IN AN EXCITING TIME 378 00:13:59,022 --> 00:14:00,290 WHERE WE ARE LEARNING EVERY DAY 379 00:14:00,290 --> 00:14:02,092 THE MANY WAYS IN WHICH 380 00:14:02,092 --> 00:14:05,529 ARTIFICIAL INTELLIGENCE WILL 381 00:14:05,529 --> 00:14:07,297 IMPROVE HUMAN HEALTH AND HEALTH 382 00:14:07,297 --> 00:14:08,899 CARE DELIVERY THOUGH WE KNOW THE 383 00:14:08,899 --> 00:14:10,367 ADVANCES COME WITH POTENTIAL 384 00:14:10,367 --> 00:14:12,636 RISK AND NEED POLICY AND 385 00:14:12,636 --> 00:14:14,571 GUIDANCE THAT PROMOTE SAFETY AND 386 00:14:14,571 --> 00:14:15,739 SECURITY IN EQUAL MEASURE. 387 00:14:15,739 --> 00:14:18,275 WITH THAT GOAL IN MIND, HHS 388 00:14:18,275 --> 00:14:21,545 DEVELOPED A ROBUST SYSTEM OF 389 00:14:21,545 --> 00:14:22,746 POLICIES AND PRACTICES THAT 390 00:14:22,746 --> 00:14:26,450 GUIDE STAKEHOLDERS ACROSS THE 391 00:14:26,450 --> 00:14:28,618 BIO MEDICAL AND RESEARCH ECO 392 00:14:28,618 --> 00:14:29,186 SYSTEM. 393 00:14:29,186 --> 00:14:32,089 THESE INCLUDE POLICIES TO 394 00:14:32,089 --> 00:14:33,857 PROTECT RESEARCH PARTICIPANTS, 395 00:14:33,857 --> 00:14:35,025 ENCOURAGE SHARING AND SHAPE THE 396 00:14:35,025 --> 00:14:36,159 PRIVACY OF HEALTH INFORMATION 397 00:14:36,159 --> 00:14:38,628 AND OF COURSE MITIGATE BIO 398 00:14:38,628 --> 00:14:43,266 SECURITY CONCERNS. 399 00:14:43,266 --> 00:14:45,535 WHILE A.I. MAY NOT BE EXPLICITLY 400 00:14:45,535 --> 00:14:48,004 MENTIONED IN EVERY POLICY, HHS'S 401 00:14:48,004 --> 00:14:51,007 POLICY FRAMEWORK IS DESIGN TO 402 00:14:51,007 --> 00:14:52,242 RESPONSIBLY GUIDE AND GOVERN 403 00:14:52,242 --> 00:14:54,911 ADVANCING SCIENCE AND EMERGING 404 00:14:54,911 --> 00:14:56,146 TECHNOLOGIES INCLUDING 405 00:14:56,146 --> 00:14:58,415 DEVELOPMENT AND USE OF A.I. 406 00:14:58,415 --> 00:14:59,649 TECHNOLOGIES IN RESEARCH. 407 00:14:59,649 --> 00:15:01,151 THAT IS EXACTLY WHY WE'VE BEEN 408 00:15:01,151 --> 00:15:03,887 WORKING WITH PARTNERS ACROSS THE 409 00:15:03,887 --> 00:15:09,159 GOVERNMENT INCLUDING MY 410 00:15:09,159 --> 00:15:11,762 CO-PRESENTERS TODAY ON THE SAFE, 411 00:15:11,762 --> 00:15:12,729 SECURE AND TRUSTWORTHY 412 00:15:12,729 --> 00:15:14,431 DEVELOPMENT AND USE OF 413 00:15:14,431 --> 00:15:14,931 ARTIFICIAL INTELLIGENCE. 414 00:15:14,931 --> 00:15:20,704 ON THE 2024 FRAMEWORK FOR 415 00:15:20,704 --> 00:15:23,407 NUCLEIC SYNTHESIS SCREENING AND 416 00:15:23,407 --> 00:15:24,808 DUAL USE RESEARCH OF CONCERN AND 417 00:15:24,808 --> 00:15:25,609 PATHOGENS WITH ENHANCED PANDEMIC 418 00:15:25,609 --> 00:15:27,944 POTENTIAL. 419 00:15:27,944 --> 00:15:32,649 THE PARTNERSHIP WE'VE HAD AT THE 420 00:15:32,649 --> 00:15:36,153 USG HAS ALLOWED US TO BALANCE 421 00:15:36,153 --> 00:15:37,687 THE RISK IN RESEARCH WITH THE 422 00:15:37,687 --> 00:15:40,524 BENEFITS TO EMERGING 423 00:15:40,524 --> 00:15:41,458 TECHNOLOGIES. 424 00:15:41,458 --> 00:15:43,727 FOR EXAMPLE, CDC IS USING 425 00:15:43,727 --> 00:15:44,795 ARTIFICIAL INTELLIGENCE AND 426 00:15:44,795 --> 00:15:55,005 MACHINE LEARNING TO ACCELERATE 427 00:15:55,005 --> 00:16:00,811 RESPONSE TO LEGIONAIR'S DISEASE. 428 00:16:00,811 --> 00:16:02,145 AND WE'RE CONTINUING TO ASSESS 429 00:16:02,145 --> 00:16:06,249 THE DEVELOPMENT OF DRUG AND 430 00:16:06,249 --> 00:16:08,485 BIOLOGICAL PRODUCTS IN DRUG 431 00:16:08,485 --> 00:16:10,020 MANUFACTURING AND IDENTIFYING 432 00:16:10,020 --> 00:16:13,457 SAFETY ISSUES AND NIH IS 433 00:16:13,457 --> 00:16:16,460 PILOTING TRIAL GPT A FIRST OF 434 00:16:16,460 --> 00:16:18,595 ITS KIND LARGE LANGUAGE MODEL 435 00:16:18,595 --> 00:16:19,830 FRAMEWORK TO ASSIST IN MATCHING 436 00:16:19,830 --> 00:16:21,364 PATIENTS TO TRIALS. 437 00:16:21,364 --> 00:16:24,167 THROUGHOUT WE CONTINUE TO FOSTER 438 00:16:24,167 --> 00:16:27,471 SOUND, SUSTAIN ADVANCED IN THE 439 00:16:27,471 --> 00:16:29,840 SCIENCES UNDERLYING MEDICINE, 440 00:16:29,840 --> 00:16:31,007 PUBLIC HEALTH AND SOCIAL 441 00:16:31,007 --> 00:16:33,143 SERVICES WHILE MAKING SURE THE 442 00:16:33,143 --> 00:16:35,245 GUARDRAILS ARE IN PLACE FOR 443 00:16:35,245 --> 00:16:37,614 RESPONSIBLE, EQUITABLE AND SAFE 444 00:16:37,614 --> 00:16:37,981 USE. 445 00:16:37,981 --> 00:16:42,352 TECHNOLOGY IS CONSTANTLY 446 00:16:42,352 --> 00:16:50,460 EVOLVING AND HHS, INCLUDING NIH 447 00:16:50,460 --> 00:16:56,533 WILL STAY NIMBLE AND MINIMIZE 448 00:16:56,533 --> 00:16:56,733 RISK. 449 00:16:56,733 --> 00:17:01,004 THIS COMMITTEE IS CRITICAL TO 450 00:17:01,004 --> 00:17:02,973 PROVIDE ADVICE ON ISSUES RELATED 451 00:17:02,973 --> 00:17:04,508 TO BIO SAFETY AND SECURITY AND 452 00:17:04,508 --> 00:17:06,510 WE THANK YOU IN ADVANCE FOR YOUR 453 00:17:06,510 --> 00:17:07,143 WORK CONSIDERING THESE CRITICAL 454 00:17:07,143 --> 00:17:14,251 ISSUES. 455 00:17:14,251 --> 00:17:16,386 BACK TO YOU, GERRY. 456 00:17:16,386 --> 00:17:18,154 >> I WANT TO THANK ALL FOLKS 457 00:17:18,154 --> 00:17:22,826 FROM THE WHITE HOUSE AND HHS FOR 458 00:17:22,826 --> 00:17:33,336 PROVIDING OPENING REMARKS AND 459 00:17:35,305 --> 00:17:36,806 THE WORK YOU'RE ABOUT TO RECEIVE 460 00:17:36,806 --> 00:17:38,508 IS IMPORTANT TO THE WHITE HOUSE 461 00:17:38,508 --> 00:17:38,875 AND HHS. 462 00:17:38,875 --> 00:17:41,511 IT'S MY HONOR TO TURN IT OVER TO 463 00:17:41,511 --> 00:17:43,613 DR. TABAK AND JORGENSON FROM THE 464 00:17:43,613 --> 00:17:46,082 NATIONAL INSTITUTES OF HEALTH TO 465 00:17:46,082 --> 00:17:48,218 DELIVER THE CHARGE TO THE BOARD. 466 00:17:48,218 --> 00:17:50,086 DR. TABAK. 467 00:17:50,086 --> 00:17:52,222 >> THANK YOU, GERRY FOR THE 468 00:17:52,222 --> 00:17:52,622 INTRODUCTION. 469 00:17:52,622 --> 00:17:55,792 AND I CERTAINLY APPRECIATE THE 470 00:17:55,792 --> 00:17:57,027 COMMENTS FROM OUR WHITE HOUSE 471 00:17:57,027 --> 00:17:57,861 AND HHS COLLEAGUES ON THIS 472 00:17:57,861 --> 00:18:03,700 IMPORTANT TOPIC. 473 00:18:03,700 --> 00:18:07,837 I'M LARRY TABAK THE PRINCIPAL 474 00:18:07,837 --> 00:18:10,373 DEPUTY DIRECTOR FROM NIH AND 475 00:18:10,373 --> 00:18:14,277 JOINED BY DR. LYRIC JORGENSON 476 00:18:14,277 --> 00:18:16,947 THE NIH ASSOCIATE DIRECTOR FOR 477 00:18:16,947 --> 00:18:18,114 SCIENCE POLICY AND WISH TO 478 00:18:18,114 --> 00:18:19,549 EXTEND A WARM WELCOME TO ALL OF 479 00:18:19,549 --> 00:18:20,317 YOU AND THANK YOU FOR JOINING 480 00:18:20,317 --> 00:18:20,917 THE DISCUSSION AROUND THE NEW 481 00:18:20,917 --> 00:18:22,686 CHARGE. 482 00:18:22,686 --> 00:18:27,357 JUST BEFORE WE MOVE TO THE MAIN 483 00:18:27,357 --> 00:18:32,796 PRESENTATION, LET ME ECHO GERRY 484 00:18:32,796 --> 00:18:40,437 AND GIVE MY THANKS TO THE ENTIRE 485 00:18:40,437 --> 00:18:43,907 COMMITTEE AND WELCOMING NEW 486 00:18:43,907 --> 00:18:46,409 MEMBERS AN THOSE VOTING AND 487 00:18:46,409 --> 00:18:48,011 EX-OFFICIO AND MY THANKS TO PAM 488 00:18:48,011 --> 00:18:50,146 AND SILVIA WHO COMPLETED THEIR 489 00:18:50,146 --> 00:18:55,385 SERVICE LAST SUMMER AND IT JOHN 490 00:18:55,385 --> 00:18:56,686 GABBENSTEIN ROLLING OFF AT THE 491 00:18:56,686 --> 00:18:58,021 END OF THIS MONTH. 492 00:18:58,021 --> 00:18:59,556 EACH WE'RE GRATEFUL FOR THEIR 493 00:18:59,556 --> 00:19:06,296 SERVICE AND CRITICAL INSIGHTS. 494 00:19:06,296 --> 00:19:09,532 AND FINALLY NO WORDS TO THANK 495 00:19:09,532 --> 00:19:11,334 YOU, GERRY, SUFFICIENTLY. 496 00:19:11,334 --> 00:19:12,502 HE'S COMPLETING HIS TERM AT THE 497 00:19:12,502 --> 00:19:13,637 END OF THE MONTH. 498 00:19:13,637 --> 00:19:16,573 YOUR DEDICATION AS CHAIR OF THE 499 00:19:16,573 --> 00:19:18,508 NSABB HAS BEEN EXTRAORDINARY AND 500 00:19:18,508 --> 00:19:23,813 ON BEHALF OF NIH, HHS WE ARE SO 501 00:19:23,813 --> 00:19:26,016 VERY VERY GRATEFUL FOR ALL 502 00:19:26,016 --> 00:19:29,853 YOU'VE DONE TO LEAD THIS 503 00:19:29,853 --> 00:19:30,754 COMMITTEE AND THE INCREDIBLE AND 504 00:19:30,754 --> 00:19:32,722 IMPORTANT IMPACTFUL WORK THAT 505 00:19:32,722 --> 00:19:38,061 YOU HAVE LAID OUT SO THANK YOU. 506 00:19:38,061 --> 00:19:40,130 >> IT'S BEEN AN HONOR TO SERVE, 507 00:19:40,130 --> 00:19:41,064 THANK YOU. 508 00:19:41,064 --> 00:19:42,365 >> RACHEL, THANK YOU FOR YOUR 509 00:19:42,365 --> 00:19:43,833 WILLINGNESS TO PICK UP THE 510 00:19:43,833 --> 00:19:50,640 MANTLE AS CHAIR OF THIS NSABB 511 00:19:50,640 --> 00:19:59,149 AND NOW I'LL DRAW YOUR ATTENTION 512 00:19:59,149 --> 00:20:00,684 TO THE SLIDE BEING DISPLAYED. 513 00:20:00,684 --> 00:20:03,620 LET ME SET THE STAGE FOR ALL 514 00:20:03,620 --> 00:20:06,122 TUNING IN WITH A QUICK RECAP OF 515 00:20:06,122 --> 00:20:07,857 WHAT THIS GROUP HAS ACCOMPLISHED 516 00:20:07,857 --> 00:20:11,227 OVER THE PAST FEW YEARS. 517 00:20:11,227 --> 00:20:14,964 ALL OF YOU ARE AWARE THAT LIFE 518 00:20:14,964 --> 00:20:17,600 SCIENCES INCLUDING STUDIES THAT 519 00:20:17,600 --> 00:20:20,570 AIM TO UNDERSTAND RAPIDLY 520 00:20:20,570 --> 00:20:23,673 EVOLVING PATHENS AN RELATED 521 00:20:23,673 --> 00:20:25,175 TESTING AND COUNTER MEASURES 522 00:20:25,175 --> 00:20:28,545 HAVE IMPORTANT BENEFITS AND ALSO 523 00:20:28,545 --> 00:20:28,912 RISKS. 524 00:20:28,912 --> 00:20:30,547 AND NIH, HHS AND THE 525 00:20:30,547 --> 00:20:33,483 U.S. GOVERNMENT AS A WHOLE 526 00:20:33,483 --> 00:20:35,685 REMAIN COMMITTED TO ENSURING 527 00:20:35,685 --> 00:20:40,290 RESEARCH ON INFECTIOUS AGENTS IS 528 00:20:40,290 --> 00:20:42,225 CONDUCTED RESPONSIBLY IN A 529 00:20:42,225 --> 00:20:44,227 MANNER THAT CONSIDERS THE 530 00:20:44,227 --> 00:20:46,730 POTENTIAL BIO SECURITY AND BIO 531 00:20:46,730 --> 00:20:49,666 SAFETY RISKS. 532 00:20:49,666 --> 00:20:51,768 NSABB MEMBERS ARE RECOGNIZED 533 00:20:51,768 --> 00:20:53,403 EXPERTS IN THEIR RESPECTIVE 534 00:20:53,403 --> 00:20:56,172 FIELDS AND THEY ARE HELP THE 535 00:20:56,172 --> 00:20:57,373 U.S. GOVERNMENT NAVIGATE VERY 536 00:20:57,373 --> 00:20:59,476 IMPORTANT QUESTIONS ABOUT SAFETY 537 00:20:59,476 --> 00:21:01,544 AND SECURITY, WHICH ALLOW US TO 538 00:21:01,544 --> 00:21:06,149 PRESERVE THE BENEFITS AND TO 539 00:21:06,149 --> 00:21:08,418 MITIGATE THE POTENTIAL RISKS. 540 00:21:08,418 --> 00:21:10,220 FOR THE LAST NSABB CHARGE WE 541 00:21:10,220 --> 00:21:13,790 REQUESTED MEMBERS TO REVIEW USG 542 00:21:13,790 --> 00:21:16,993 POLICIES RELATED TO HIGHER RISK 543 00:21:16,993 --> 00:21:21,531 WORK WITH PATHOGENS AND THE 544 00:21:21,531 --> 00:21:24,067 RECOMMENDATIONS WE'VE ALLUDED TO 545 00:21:24,067 --> 00:21:25,769 OUTLINED PROPOSED BIO SECURITY 546 00:21:25,769 --> 00:21:28,438 FRAMEWORK FOR THE FUTURE OF 547 00:21:28,438 --> 00:21:31,875 SCIENCE AS WELL AS INPUTS FROM 548 00:21:31,875 --> 00:21:34,177 THE PUBLIC WERE INSTRUMENTAL IN 549 00:21:34,177 --> 00:21:36,045 INFORMING THE DEVELOPMENT OF THE 550 00:21:36,045 --> 00:21:39,883 RECENTLY RELEASED USG POLICY FOR 551 00:21:39,883 --> 00:21:40,917 OVERSIGHT OF DUAL USE RESEARCH 552 00:21:40,917 --> 00:21:45,989 OF CONCERN AND PATHOGENS WITH 553 00:21:45,989 --> 00:21:46,923 ENHANCED PANDEMIC POTENTIAL 554 00:21:46,923 --> 00:21:50,326 WHICH IS SOMETIMES REFERRED TO 555 00:21:50,326 --> 00:21:55,532 AS THE DIRK-PEP POLICY. 556 00:21:55,532 --> 00:21:57,634 THIS POLICY ISSUED IN MAY OF 557 00:21:57,634 --> 00:22:02,005 2024 AND EFFECTIVE IN MAY OF 558 00:22:02,005 --> 00:22:04,040 2025 CREATES A UNIFIED FEDERAL 559 00:22:04,040 --> 00:22:06,142 OVERSIGHT FRAMEWORK THAT 560 00:22:06,142 --> 00:22:09,012 ADDRESSES OVERSIGHT OF RESEARCH 561 00:22:09,012 --> 00:22:11,748 ON BIOLOGICAL AGENTS AND TOXINS 562 00:22:11,748 --> 00:22:13,783 THAT WHEN ENHANCED HAVE THE 563 00:22:13,783 --> 00:22:17,220 POTENTIAL TO POSE RISK TO PUBLIC 564 00:22:17,220 --> 00:22:19,956 HEALTH, AGRICULTURE, FOOD 565 00:22:19,956 --> 00:22:22,625 SAFETY, ECONOMIC SECURITY OR 566 00:22:22,625 --> 00:22:24,027 NATIONAL SECURITY. 567 00:22:24,027 --> 00:22:28,031 WE'RE SO VERY GRATEFUL TO THE 568 00:22:28,031 --> 00:22:32,435 NSABB FOR CRITICAL GUIDANCE IN 569 00:22:32,435 --> 00:22:35,505 FORMING THE POLICY AND WE WANT 570 00:22:35,505 --> 00:22:36,673 TO POINT TO THOSE WATCHING TODAY 571 00:22:36,673 --> 00:22:38,675 TO THE LINK SHOWN AT THE BOTTOM 572 00:22:38,675 --> 00:22:42,579 THEY'RE INTERESTED IN ADDITIONAL 573 00:22:42,579 --> 00:22:42,879 INFORMATION. 574 00:22:42,879 --> 00:22:50,119 IF WE HAVE THE NEXT SLIDE, 575 00:22:50,119 --> 00:22:50,353 PLEASE. 576 00:22:50,353 --> 00:22:56,559 SO, THE POLICY LOOKS AT BIOLOGY 577 00:22:56,559 --> 00:22:57,961 AND INCREASING USE OF 578 00:22:57,961 --> 00:23:00,263 COMPUTATIONAL MODELS AND 579 00:23:00,263 --> 00:23:06,536 APPROACHES INCLUDING ARTIFICIAL 580 00:23:06,536 --> 00:23:09,873 INTELLIGENCE THAT PLAY MAY 581 00:23:09,873 --> 00:23:16,112 PRODUCTION TO THE DUAL-USE 582 00:23:16,112 --> 00:23:16,746 BIOLOGIC INFORMATION AND 583 00:23:16,746 --> 00:23:18,548 TECHNOLOGY AND PRODUCTS. 584 00:23:18,548 --> 00:23:20,650 AS MANY ARE AWARE THERE'S 585 00:23:20,650 --> 00:23:22,118 EXTENSIVE DISCUSSIONS AND 586 00:23:22,118 --> 00:23:23,152 COORDINATED ACTS ACROSS THE 587 00:23:23,152 --> 00:23:25,521 U.S. GOVERNMENT IN RESPONSE TO 588 00:23:25,521 --> 00:23:29,525 THE RAPID EVOLUTION OF IN SILICO 589 00:23:29,525 --> 00:23:31,761 APPROACHES INCLUDING ARTIFICIAL 590 00:23:31,761 --> 00:23:32,562 INTELLIGENCE. 591 00:23:32,562 --> 00:23:40,436 THIS HAS LEAD TO A SUITE OF 592 00:23:40,436 --> 00:23:41,738 INNOVATION WHILE PROTECTING 593 00:23:41,738 --> 00:23:42,472 PUBLIC SAFETY AND NATIONAL 594 00:23:42,472 --> 00:23:42,739 SECURITY. 595 00:23:42,739 --> 00:23:44,274 I'D LIKE TO HIGHLIGHT A FEW 596 00:23:44,274 --> 00:23:49,279 RECENT AND ONGOING EFFORTS THAT 597 00:23:49,279 --> 00:23:53,349 RELATE TO THE NSABB'S PURVIEW TO 598 00:23:53,349 --> 00:23:58,421 HELP SET THE STAGE FOR TODAY'S 599 00:23:58,421 --> 00:23:58,655 CHARGE. 600 00:23:58,655 --> 00:24:02,258 IN 2023 PRESIDENT BIDEN SIGNED 601 00:24:02,258 --> 00:24:03,893 EXECUTIVE ORDER 14110 ON SAFE, 602 00:24:03,893 --> 00:24:06,162 SECURITY AND TRUSTWORTHY 603 00:24:06,162 --> 00:24:07,096 DEVELOPMENT AND USE OF 604 00:24:07,096 --> 00:24:07,764 ARTIFICIAL INTELLIGENCE 605 00:24:07,764 --> 00:24:10,633 PROVIDING A STRATEGY TO HARNESS 606 00:24:10,633 --> 00:24:12,168 POTENTIAL BENEFITS FROM A.I. 607 00:24:12,168 --> 00:24:16,306 WHILE MITIGATING RISKS. 608 00:24:16,306 --> 00:24:20,443 AND THERE WERE SEVERAL OUTPUTS 609 00:24:20,443 --> 00:24:21,811 RELEVANT TODAY. 610 00:24:21,811 --> 00:24:27,717 FIRST, A NATIONAL SECURITY MEMO 611 00:24:27,717 --> 00:24:32,121 WAS RELEASED TO PROVIDE FURTHER 612 00:24:32,121 --> 00:24:33,823 DIRECTION ON HARNESSING A.I. 613 00:24:33,823 --> 00:24:35,925 MODELS AND A.I. ENABLED 614 00:24:35,925 --> 00:24:36,292 TECHNOLOGIES. 615 00:24:36,292 --> 00:24:41,230 THIS INCLUDE CONSIDERATIONS TO 616 00:24:41,230 --> 00:24:42,598 RESEARCH USING A.I. 617 00:24:42,598 --> 00:24:45,168 AT THE OUTSET SAFEGUARDS WERE 618 00:24:45,168 --> 00:24:48,805 NEEDED TO ENSURE IN SILICO 619 00:24:48,805 --> 00:24:50,340 RESEARCH WITH DUEL-USE 620 00:24:50,340 --> 00:24:54,444 IMPLICATIONS WERE MANAGED AND 621 00:24:54,444 --> 00:24:55,712 CONTROLLED TO THE NATIONAL 622 00:24:55,712 --> 00:24:57,113 ACADEMIES CONSENSUS STUDY IS 623 00:24:57,113 --> 00:24:59,182 UNDERWAY ON ASSESSING AND 624 00:24:59,182 --> 00:25:00,550 NAVIGATING BIO SECURITY CONCERNS 625 00:25:00,550 --> 00:25:03,319 AND BENEFITS OF ARTIFICIAL 626 00:25:03,319 --> 00:25:08,257 INTELLIGENCE USE IN THE LIFE 627 00:25:08,257 --> 00:25:10,560 SCIENC 628 00:25:10,560 --> 00:25:12,695 SCIENCES WE KNOW THERE'S A NEED 629 00:25:12,695 --> 00:25:15,365 TO MITIGATE CERTAIN BIO SECURITY 630 00:25:15,365 --> 00:25:18,101 CHALLENGES WITH THE USE OF A.I. 631 00:25:18,101 --> 00:25:20,303 AND WITH THE USE OF SYNTHETIC 632 00:25:20,303 --> 00:25:22,038 NUCLEIC ACIDS AND WE'RE EXCITED 633 00:25:22,038 --> 00:25:24,073 ABOUT THE POTENTIAL OF A.I. 634 00:25:24,073 --> 00:25:26,609 MODELS AND HELPING US UNDERSTAND 635 00:25:26,609 --> 00:25:28,311 THE STRUCTURE AND FUNCTION OF 636 00:25:28,311 --> 00:25:28,711 BIO MOLECULES. 637 00:25:28,711 --> 00:25:31,814 BUT OF COURSE THERE IS CONCERN 638 00:25:31,814 --> 00:25:33,783 THIS TECHNOLOGY MAY MAKE IT 639 00:25:33,783 --> 00:25:35,151 EASIER TO DESIGN AND GENERATE 640 00:25:35,151 --> 00:25:39,055 NEW PATHOGENS OR TOXINS. 641 00:25:39,055 --> 00:25:41,024 TO LIMIT THIS POTENTIAL, 642 00:25:41,024 --> 00:25:44,127 U.S. GOVERNMENT AGENCIES HAVE 643 00:25:44,127 --> 00:25:46,095 DEVELOPED A FRAMEWORK WHERE 644 00:25:46,095 --> 00:25:47,930 SYNTHETIC NUCLEIC ACID SCREENING 645 00:25:47,930 --> 00:25:50,633 FOR SEQUENCES OF CONCERN THAT 646 00:25:50,633 --> 00:25:52,068 ESTABLISH REQUIREMENTS THAT 647 00:25:52,068 --> 00:25:54,303 FEDERALLY FUNDED RESEARCHERS 648 00:25:54,303 --> 00:25:58,341 MUST ORDER FROM PROVIDERS THAT 649 00:25:58,341 --> 00:26:02,278 FOLLOW THIS FRAMEWORK. 650 00:26:02,278 --> 00:26:03,846 AND BEFORE IN SILICO MODELLING 651 00:26:03,846 --> 00:26:06,516 IS COMPLETED AND DATA SETS 652 00:26:06,516 --> 00:26:09,485 AVAILABLE IT'S CRITICAL TO 653 00:26:09,485 --> 00:26:10,620 SAFEGUARD AGAINST ANYTHING THAT 654 00:26:10,620 --> 00:26:13,156 COULD LEAD TO BIO SECURITY RISK. 655 00:26:13,156 --> 00:26:18,161 WITH THIS IN MIND THE NATIONAL 656 00:26:18,161 --> 00:26:22,632 ACADEMIES IS PLANNING A WORKSHOP 657 00:26:22,632 --> 00:26:24,434 OF IN SILICO IN SILICO AND 658 00:26:24,434 --> 00:26:25,768 APPROACH OF BIOLOGICAL AGENTS 659 00:26:25,768 --> 00:26:28,471 AND ORGANISMS AND WE LOOK 660 00:26:28,471 --> 00:26:33,976 FORWARD TO THAT WORKSHOP REPORT 661 00:26:33,976 --> 00:26:43,319 IN 2025. 662 00:26:43,319 --> 00:26:45,922 WHAT IS NEXT? 663 00:26:45,922 --> 00:26:46,889 THOUGH MUCH PROGRESS HAS BEEN 664 00:26:46,889 --> 00:26:52,161 MADE WE NEED A MORE GRANULAR 665 00:26:52,161 --> 00:26:56,332 RHODE ISLAND -- RODE MAPPING 666 00:26:56,332 --> 00:26:58,101 AND DEVELOPED THE NEXT CHARGE 667 00:26:58,101 --> 00:27:00,436 BASED ON THREE HIGH-LEVEL ISSUES 668 00:27:00,436 --> 00:27:08,578 THAT BUILD ON THE 2024 DIRK PAP 669 00:27:08,578 --> 00:27:10,980 POLICY AND PREVIOUS NSABB 670 00:27:10,980 --> 00:27:11,347 RECOMMENDATIONS. 671 00:27:11,347 --> 00:27:16,886 FIRST, WE THINK THERE'S MORE TO 672 00:27:16,886 --> 00:27:18,855 BE DONE TO IDENTIFY AND ASSESS 673 00:27:18,855 --> 00:27:21,858 THE RISK OF MODELS WITH DUAL USE 674 00:27:21,858 --> 00:27:23,493 POTENTIAL FOR CONDUCTING 675 00:27:23,493 --> 00:27:27,997 RESEARCH THROUGH COMPUTATIONAL 676 00:27:27,997 --> 00:27:28,931 ATTORNEY GE 677 00:27:28,931 --> 00:27:33,002 STRATEGIES THAT MAKE THE NOVEL 678 00:27:33,002 --> 00:27:36,806 BIOLOGICAL AGENT OR TOXIN MORE 679 00:27:36,806 --> 00:27:37,173 ACCESSIBLE. 680 00:27:37,173 --> 00:27:38,407 AND AFTER IDENTIFYING THE RISK 681 00:27:38,407 --> 00:27:41,477 AND BENEFITS WE NEED GUIDANCE 682 00:27:41,477 --> 00:27:43,379 FOR RISK MITIGATION TO 683 00:27:43,379 --> 00:27:45,348 STRENGTHEN SAFETY AND BOLSTER 684 00:27:45,348 --> 00:27:47,917 THE TRUSTWORTHINESS OF THIS 685 00:27:47,917 --> 00:27:52,722 RESEARCH AND FINALLY METHODS TO 686 00:27:52,722 --> 00:27:54,323 RESPONSIBLY COMMUNICATE PRODUCTS 687 00:27:54,323 --> 00:27:55,591 AND RESEARCH THE COMMUNITY ON 688 00:27:55,591 --> 00:27:57,059 POTENTIAL MISUSE, RISKS AND 689 00:27:57,059 --> 00:28:00,163 MITIGATION STRATEGIES. 690 00:28:00,163 --> 00:28:04,800 IF I MAY HAVE THE NEXT SLIDE. 691 00:28:04,800 --> 00:28:08,204 THAT BRINGS US TO OUR CHARGE FOR 692 00:28:08,204 --> 00:28:09,539 THE NSABB COMMITTEE TODAY. 693 00:28:09,539 --> 00:28:12,141 BASED ON THESE HIGH-LEVEL NEEDS 694 00:28:12,141 --> 00:28:15,311 I'VE OUTLINED WE HAVE SPLIT THE 695 00:28:15,311 --> 00:28:16,846 CHARGE INTO THREE PARTS AND WE 696 00:28:16,846 --> 00:28:20,816 HAVE DELINEATED THEM INTO TWO 697 00:28:20,816 --> 00:28:21,551 PHASE TO PROMPT DISCUSSION ON 698 00:28:21,551 --> 00:28:24,453 THE TIME LINE FOR THE WORK. 699 00:28:24,453 --> 00:28:26,022 PHASE 1 HAS TWO MAJOR DON'TS. 700 00:28:26,022 --> 00:28:29,592 THIS FIRST, 1A IS CENTERED ON 701 00:28:29,592 --> 00:28:31,727 IDENTIFYING AND ASSESSING RISKS 702 00:28:31,727 --> 00:28:33,496 AND BENEFITS. 703 00:28:33,496 --> 00:28:37,066 WE ASK THE NSABB TO RECOMMEND 704 00:28:37,066 --> 00:28:38,668 STRATEGIES FOR IDENTIFYING AND 705 00:28:38,668 --> 00:28:41,804 OPTIONS FOR MITIGATING POTENTIAL 706 00:28:41,804 --> 00:28:44,507 RISKS ASSOCIATED WITH IN SILICO 707 00:28:44,507 --> 00:28:47,677 RESEARCH, COMPUTATIONAL MODELS 708 00:28:47,677 --> 00:28:50,813 INCLUDING A.I. MODELS AND DATA 709 00:28:50,813 --> 00:28:53,583 SETS AND LIFE SCIENCE SETTINGS. 710 00:28:53,583 --> 00:28:55,785 THIS INCLUDES IDENTIFYING 711 00:28:55,785 --> 00:28:57,753 APPROACHES, ABILITY AND 712 00:28:57,753 --> 00:29:00,456 PROPENSITY OF MODELS THAT COULD 713 00:29:00,456 --> 00:29:01,724 RESULT IN THE DEVELOPMENT OF 714 00:29:01,724 --> 00:29:04,260 DUAL USE INFORMATION OR MODELS 715 00:29:04,260 --> 00:29:06,329 DIRECTLY ENABLING THE DESIGN OF 716 00:29:06,329 --> 00:29:11,334 A PATHOGEN WITH ENHANCED 717 00:29:11,334 --> 00:29:13,302 PANDEMIC POTENTIAL OR NOVEL B 718 00:29:13,302 --> 00:29:16,872 BIOLOGIC AGENT OR TOXIN AND 719 00:29:16,872 --> 00:29:20,810 ASSESSING THESE RISKS AGAINST 720 00:29:20,810 --> 00:29:23,379 YEAR CRITERIA AND PUBLISHING 721 00:29:23,379 --> 00:29:25,581 RISK RESULTS AN HOW IN SILICO 722 00:29:25,581 --> 00:29:27,416 RESEARCH CAN AID IN THE DESIGN, 723 00:29:27,416 --> 00:29:30,453 DEVELOPMENT, ENHANCEMENT OR 724 00:29:30,453 --> 00:29:33,656 ACQUISITION OF TRANSMISSIBLE 725 00:29:33,656 --> 00:29:34,323 BIOLOGICAL AGENTS WITH SPECIFIC 726 00:29:34,323 --> 00:29:41,030 ATTRIBUTES. 727 00:29:41,030 --> 00:29:46,669 THIS IS THE SECOND PHASE, PHASE 728 00:29:46,669 --> 00:29:46,836 1B. 729 00:29:46,836 --> 00:29:51,674 THIS COULD BE DONE IN CONCERT 730 00:29:51,674 --> 00:29:53,776 WITH PHASE 1A LOOKING AT 731 00:29:53,776 --> 00:29:57,113 STRATEGIES WHILE DEFINING 732 00:29:57,113 --> 00:29:58,748 BENEFITS AND RISK OF RESEARCH. 733 00:29:58,748 --> 00:30:02,718 HERE WE CHARGE THE NSABB TO 734 00:30:02,718 --> 00:30:05,888 OUTLINE OPTIONS INCLUDING 735 00:30:05,888 --> 00:30:08,457 METHODS AND APPROACHES TO 736 00:30:08,457 --> 00:30:10,426 INCORPORATE CURRENT FUTURE 737 00:30:10,426 --> 00:30:14,397 GUIDELINES AND STANDARDS FOR 738 00:30:14,397 --> 00:30:16,565 RISKS OF DUAL USE, MODELS 739 00:30:16,565 --> 00:30:18,167 DEVELOPED BY THE STANDARDS OF 740 00:30:18,167 --> 00:30:19,435 INFORMATION AND TECHNOLOGY TO 741 00:30:19,435 --> 00:30:22,071 THE DEVELOPMENT AND RELEASE OF 742 00:30:22,071 --> 00:30:24,407 DUAL-USE A.I. MODELS, DATA SETS 743 00:30:24,407 --> 00:30:25,741 AND RESEARCH RESULTS. 744 00:30:25,741 --> 00:30:30,179 SECOND TO MITIGATE THE RISK OF 745 00:30:30,179 --> 00:30:33,683 MISUSE OF DEPLOYED MODELS AND 746 00:30:33,683 --> 00:30:35,951 API LEVEL SAFEGUARDS AND 747 00:30:35,951 --> 00:30:37,119 CUSTOMER PRACTICES THAT COULD 748 00:30:37,119 --> 00:30:39,355 IDENTIFY POTENTIAL CASES OF 749 00:30:39,355 --> 00:30:42,325 MISUSE WITH MINIMAL DISRUPTION 750 00:30:42,325 --> 00:30:46,062 TO LEGITIMATE USERS AND TO 751 00:30:46,062 --> 00:30:46,562 SELECT THE APPROPRIATE 752 00:30:46,562 --> 00:30:50,199 MITIGATION STRATEGIES THAT ARE 753 00:30:50,199 --> 00:30:51,701 COMMENSURATE TO THE POTENTIAL 754 00:30:51,701 --> 00:30:54,103 RISK AND BENEFIT OF THE DUAL USE 755 00:30:54,103 --> 00:30:55,204 A.I. MODEL OF DATA SETS. 756 00:30:55,204 --> 00:31:04,613 IF I MAY HAVE THE NEXT SLIDE. 757 00:31:04,613 --> 00:31:05,915 THIS TRAAKES US TO THE SECOND 758 00:31:05,915 --> 00:31:08,117 PHASE OF THE EFFORT AND CHARGE 759 00:31:08,117 --> 00:31:14,623 THE NSABB TO DELINEATE 760 00:31:14,623 --> 00:31:17,093 RESPONSIBLE METHODS IN THE 761 00:31:17,093 --> 00:31:18,627 SECOND EFFORT AND EXPLORE 762 00:31:18,627 --> 00:31:21,731 OPTIONS INCLUDING METHODS AND 763 00:31:21,731 --> 00:31:24,867 APPROACHES TO RESPONSIBLY SHARE 764 00:31:24,867 --> 00:31:27,470 AND COMMUNICATE RESEARCH RESULTS 765 00:31:27,470 --> 00:31:30,706 IN DATA SETS IN REPOSITORIES AND 766 00:31:30,706 --> 00:31:33,075 PREPRINTS AND PEER-REVIEWED 767 00:31:33,075 --> 00:31:34,577 PUBLICATIONS INCLUDING DECISIONS 768 00:31:34,577 --> 00:31:36,779 AND STRUCTURED ACCESS PARADIGMS 769 00:31:36,779 --> 00:31:39,749 FOR HOSTING DUAL-USE MODELS AND 770 00:31:39,749 --> 00:31:41,117 DATA SETS. 771 00:31:41,117 --> 00:31:45,654 AND WANT TO EDUCATE THE 772 00:31:45,654 --> 00:31:46,689 SCIENTIFIC COMMUNITY AND ENHANCE 773 00:31:46,689 --> 00:31:48,157 INSTITUTIONAL AWARENESS AND 774 00:31:48,157 --> 00:31:49,625 OVERSIGHT OF THE POTENTIAL 775 00:31:49,625 --> 00:31:55,531 MISUSE, RISKS AND MITIGATION 776 00:31:55,531 --> 00:31:56,165 STRATEGIES. 777 00:31:56,165 --> 00:31:57,233 GIVEN THE GREAT IMPORTANCE OF 778 00:31:57,233 --> 00:31:59,702 THIS TOPIC WE ARE PROPOSING THE 779 00:31:59,702 --> 00:32:01,003 BOARD WORK ON AN EXPEDITED TIME 780 00:32:01,003 --> 00:32:07,576 LINE WRAPPING UP BY THE END OF 781 00:32:07,576 --> 00:32:07,977 2025. 782 00:32:07,977 --> 00:32:09,445 HOW YOU APPROACH THE CHARGE IS 783 00:32:09,445 --> 00:32:17,186 UP TO THE COMMITTEE BUT YOU SEE 784 00:32:17,186 --> 00:32:21,891 DISPLAYED A TIME LINE TO START 785 00:32:21,891 --> 00:32:23,325 THE DISCUSSION AND HAVE A 786 00:32:23,325 --> 00:32:25,628 WORKING GROUP TO ADDRESS THE 787 00:32:25,628 --> 00:32:27,696 CHARGE AND BRING IN INDIVIDUALS 788 00:32:27,696 --> 00:32:28,497 WITH RELEVANT EXPERTISE. 789 00:32:28,497 --> 00:32:32,134 OF COURSE THE WORKING GROUP WILL 790 00:32:32,134 --> 00:32:33,602 BENEFIT FROM UNDERSTANDING 791 00:32:33,602 --> 00:32:35,104 EXPERT AT THE LEADING EDGE OF 792 00:32:35,104 --> 00:32:37,873 THE IN SILICO RESEARCH EFFORTS 793 00:32:37,873 --> 00:32:38,974 AND COMPUTATIONAL MODELS 794 00:32:38,974 --> 00:32:41,377 INCLUDING A.I. AND DATA SETS AND 795 00:32:41,377 --> 00:32:43,045 LIFE SCIENCE SETTINGS. 796 00:32:43,045 --> 00:32:44,647 OTHERS WHO HAVE BEEN THINKING 797 00:32:44,647 --> 00:32:47,650 DEEPLY HOW TO EVALUATE AND 798 00:32:47,650 --> 00:32:48,918 MITIGATE RISK AND THOSE WITH 799 00:32:48,918 --> 00:32:51,687 REAL STRONG UNDERSTANDING OF THE 800 00:32:51,687 --> 00:32:54,223 EVOLVING BIO SECURITY AND 801 00:32:54,223 --> 00:32:55,591 ETHICAL, LEGAL AND SOCIAL 802 00:32:55,591 --> 00:32:57,059 IMPLICATIONS OF SUCH RESEARCH. 803 00:32:57,059 --> 00:33:00,629 THIS WORKING GROUP SHOULD KICK 804 00:33:00,629 --> 00:33:03,199 OFF WE HOPE BY JANUARY OF 2025. 805 00:33:03,199 --> 00:33:04,934 ALONG THE WAY WE HOPE THE 806 00:33:04,934 --> 00:33:06,168 WORKING GROUP WILL BE INFORMED 807 00:33:06,168 --> 00:33:08,704 BY CONCURRENT EFFORTS SUCH AS 808 00:33:08,704 --> 00:33:14,777 THE ACADEMIES' EFFORTS AND INPUT 809 00:33:14,777 --> 00:33:17,046 FROM THE PUBLIC AND SUBJECT 810 00:33:17,046 --> 00:33:18,013 MATTER EXPERTS. 811 00:33:18,013 --> 00:33:19,715 WE ASK THE NSABB REPORT OUT IN 812 00:33:19,715 --> 00:33:21,317 TWO WAYS. 813 00:33:21,317 --> 00:33:23,285 FIRST, BY PROVIDING AN INTERIM 814 00:33:23,285 --> 00:33:26,255 REPORT IN THE SUMMER OF 2025 AND 815 00:33:26,255 --> 00:33:29,992 SECOND BY DECEMBER OF 2025 816 00:33:29,992 --> 00:33:30,860 PROVIDING RECOMMENDATIONS AND A 817 00:33:30,860 --> 00:33:34,163 FINAL RECORD INCLUDING FINDINGS 818 00:33:34,163 --> 00:33:36,131 AND STRATEGIES TO INFORM FUTURE 819 00:33:36,131 --> 00:33:37,967 U.S. GOVERNMENT DISCUSSION 820 00:33:37,967 --> 00:33:43,539 REGARDING OUR OVERSIGHT 821 00:33:43,539 --> 00:33:46,342 FRAMEWORKS AND PRACTICES AROUND 822 00:33:46,342 --> 00:33:48,878 IN SILICO RESEARCH AND 823 00:33:48,878 --> 00:33:50,613 COMPUTATIONAL MODELS WITH 824 00:33:50,613 --> 00:33:51,747 POTENTIAL DATA SECURITY RISK AND 825 00:33:51,747 --> 00:34:02,191 ULTIMATELY ENSURING SAFETY AND 826 00:34:02,191 --> 00:34:03,325 MINIMIZING RISK TO PUBLIC 827 00:34:03,325 --> 00:34:03,559 HEALTH. 828 00:34:03,559 --> 00:34:08,364 WE APPRECIATE THIS IS GOING TO 829 00:34:08,364 --> 00:34:16,972 BE A LIFT -- WE ONLY WOULD TO 830 00:34:16,972 --> 00:34:21,477 PEOPLE NOT BUSY -- NO, WE KNOW 831 00:34:21,477 --> 00:34:23,279 HOW BUSY YOU ARE BUT YOU HAVE 832 00:34:23,279 --> 00:34:24,647 EXPERTISE IN THESE ISSUES AND 833 00:34:24,647 --> 00:34:27,182 WITH THAT I'LL TURN IT TO GERRY 834 00:34:27,182 --> 00:34:28,884 FOR NSABB MEMBER DISCUSSION 835 00:34:28,884 --> 00:34:29,919 REGARDING THE CHARGE AND WE 836 00:34:29,919 --> 00:34:31,820 CERTAINLY LOOK FORWARD TO THE 837 00:34:31,820 --> 00:34:33,122 CONVERSATION. 838 00:34:33,122 --> 00:34:33,322 GERRY. 839 00:34:33,322 --> 00:34:41,196 >> THANK YOU, DR. TABAK. 840 00:34:41,196 --> 00:34:42,531 THANK YOU FOR THE EXCELLENT 841 00:34:42,531 --> 00:34:42,865 PRESENTATION. 842 00:34:42,865 --> 00:34:45,000 IT'S A TIMELY CHARGE AND YES, 843 00:34:45,000 --> 00:34:46,702 THE TIME LINES ARE AGGRESSIVE 844 00:34:46,702 --> 00:34:50,806 BUT I THINK THE ISSUES DEMAND 845 00:34:50,806 --> 00:34:52,942 THE BOARD APPROACH THIS 846 00:34:52,942 --> 00:34:54,176 AGGRESSIVE TIME LINE IN A 847 00:34:54,176 --> 00:34:57,279 SERIOUS AND THOUGHTFUL MANNER. 848 00:34:57,279 --> 00:34:59,381 MAYBE THAT'S EASY FOR MANY TO 849 00:34:59,381 --> 00:35:01,584 SAY SINCE I'M GOING OFF THE 850 00:35:01,584 --> 00:35:02,952 BOARD BUT NONETHELESS IT'S A 851 00:35:02,952 --> 00:35:04,119 TIMELY CHARGE AND KNOW THE BOARD 852 00:35:04,119 --> 00:35:06,622 IS READY TO GO BACK TO WORK. 853 00:35:06,622 --> 00:35:10,292 WITH THAT I WANT IT TURN TO MY 854 00:35:10,292 --> 00:35:18,300 MEMBERS OF NSABB IF YOU HAVE 855 00:35:18,300 --> 00:35:19,168 IMMEDIATE QUESTIONS OR IF 856 00:35:19,168 --> 00:35:22,204 THERE'S QUESTIONS ON THE CHARGE 857 00:35:22,204 --> 00:35:24,239 ON THE PROCESS YOU'LL BE 858 00:35:24,239 --> 00:35:24,873 DEVELOPING AS YOU THINK ABOUT 859 00:35:24,873 --> 00:35:29,979 MOVING FORWARD. 860 00:35:29,979 --> 00:35:35,351 AND OF COURSE THERE'LL BE 861 00:35:35,351 --> 00:35:37,419 WORKING GROUPS ESTABLISHED VERY 862 00:35:37,419 --> 00:35:41,190 SOON JANUARY 2025 IS COMING UP 863 00:35:41,190 --> 00:35:43,926 QUICK. 864 00:35:43,926 --> 00:35:45,461 THOSE WILL BE FORMING AND I'M 865 00:35:45,461 --> 00:35:48,430 SURE YOU'LL HAVE AN OPPORTUNITY 866 00:35:48,430 --> 00:35:52,901 TO SHAPE THE PATH FORWARD TO 867 00:35:52,901 --> 00:35:54,603 BEAT THE AGGRESSIVE TIME LINE. 868 00:35:54,603 --> 00:36:00,175 >> THERE WERE TWO BIG STUDIES 869 00:36:00,175 --> 00:36:05,414 BEING DONE THERE WAS ONE AT THE 870 00:36:05,414 --> 00:36:06,181 NATIONAL ACADEMY AND -- 871 00:36:06,181 --> 00:36:09,585 >> ANOTHER ONE IS BEING DONE 872 00:36:09,585 --> 00:36:11,220 WITH NSF AROUND RESPONSIBLE 873 00:36:11,220 --> 00:36:21,463 PUBLICATIONS. 874 00:36:35,711 --> 00:36:42,284 >> WE AT THE NSF WORKSHOP WILL 875 00:36:42,284 --> 00:36:45,654 BE IN EARLY AND THEY'LL BE 876 00:36:45,654 --> 00:36:46,288 DEVELOPING PROCEEDINGS OF THE 877 00:36:46,288 --> 00:36:52,961 WORKSHOP FOLLOWING THAT. 878 00:36:52,961 --> 00:36:59,034 >> WE MADE SURE THE FINDINGS YOU 879 00:36:59,034 --> 00:37:04,106 ARE INFORMED SO THERE'S SYNERGY 880 00:37:04,106 --> 00:37:04,773 ACROSS THE EFFORT. 881 00:37:04,773 --> 00:37:08,777 >> INTRODUCE THE WORKING GROUP 882 00:37:08,777 --> 00:37:11,580 TO THOSE AND CERTAINLY HAVE THEM 883 00:37:11,580 --> 00:37:13,549 BRIEF WHAT THEY'RE DOING AND 884 00:37:13,549 --> 00:37:14,950 ALSO THAT'S A GREAT IDEA TO BE 885 00:37:14,950 --> 00:37:24,259 ABLE TO ATTEND OTHER MEETINGS. 886 00:37:24,259 --> 00:37:25,461 >> THANK YOU ALL FOR PROVIDING 887 00:37:25,461 --> 00:37:27,429 THE UPDATED CHARGE. 888 00:37:27,429 --> 00:37:29,064 IT'S REALLY IMPORTANT AS WAS 889 00:37:29,064 --> 00:37:29,631 JUST SHARED. 890 00:37:29,631 --> 00:37:31,467 MY QUESTION IS REALLY MORE 891 00:37:31,467 --> 00:37:32,801 RELATED TO THE PRIVATE SECTOR. 892 00:37:32,801 --> 00:37:34,069 SO MUCH OF THIS RESEARCH IS 893 00:37:34,069 --> 00:37:36,672 BEING DONE IN THE PRIVATE 894 00:37:36,672 --> 00:37:37,106 SECTOR. 895 00:37:37,106 --> 00:37:40,242 AS WE DEVELOP THE 896 00:37:40,242 --> 00:37:40,876 RECOMMENDATIONS AND HOPING 897 00:37:40,876 --> 00:37:42,444 LOOKING AT THE IMPLEMENTATION 898 00:37:42,444 --> 00:37:43,846 WHAT ARE THE THOUGHTS OF THE 899 00:37:43,846 --> 00:37:46,014 PRIVATE SECTOR AND HOW CAN WE 900 00:37:46,014 --> 00:37:48,784 ENSURE THAT THESE ARE ALSO 901 00:37:48,784 --> 00:37:50,619 ADOPTED BY THAT PARTICULAR 902 00:37:50,619 --> 00:37:53,489 SECTOR SINCE IT'S SO LARGE AND 903 00:37:53,489 --> 00:37:54,089 MUCH OF THE RESEARCH IS BEING 904 00:37:54,089 --> 00:38:00,896 DONE THERE. 905 00:38:00,896 --> 00:38:01,897 >> IT'S VERY IMPORTANT. 906 00:38:01,897 --> 00:38:04,833 >> AS THE MEMBERS THINK ABOUT 907 00:38:04,833 --> 00:38:07,202 THIS AND THINK OF THE START-UP I 908 00:38:07,202 --> 00:38:09,004 CHALLENGE YOU TO THINK ABOUT THE 909 00:38:09,004 --> 00:38:10,773 STAKE HOLDERS YOU WANT TO BRING 910 00:38:10,773 --> 00:38:17,780 IN AND HEAR FROM AND GET THEIR 911 00:38:17,780 --> 00:38:19,948 THOUGHTS ON THE IMPACT TO THE 912 00:38:19,948 --> 00:38:21,116 PRIVATE SECTOR AND HOW TO BE 913 00:38:21,116 --> 00:38:22,050 ENGAGED FROM THE START WILL BE 914 00:38:22,050 --> 00:38:23,786 IMPORTANT, I THINK. 915 00:38:23,786 --> 00:38:25,754 >> AND THIS IS SOMETHING THAT WE 916 00:38:25,754 --> 00:38:28,123 ACROSS THE ENTIRETIY OF 917 00:38:28,123 --> 00:38:30,159 GOVERNMENT HAVE BEEN THINKING 918 00:38:30,159 --> 00:38:30,559 ABOUT. 919 00:38:30,559 --> 00:38:34,696 YOU'VE SEEN RECENT PUBLICATIONS 920 00:38:34,696 --> 00:38:37,099 FROM COLLEAGUES REGARDING 921 00:38:37,099 --> 00:38:38,634 SYNTHETIC BIOLOGY AND 922 00:38:38,634 --> 00:38:42,671 PROCUREMENT STANDARDS AND HHS IS 923 00:38:42,671 --> 00:38:45,841 WORKING CLOSELY IN THE MODELS 924 00:38:45,841 --> 00:38:50,813 WITH PRIVATE SECTOR ACROSS 925 00:38:50,813 --> 00:38:54,817 GENERATIVE AND MULTIMODAL A.I. 926 00:38:54,817 --> 00:38:57,019 AND HAVE MEANINGFUL 927 00:38:57,019 --> 00:38:59,621 PARTICIPATION BY THE PRIVATE 928 00:38:59,621 --> 00:39:05,961 SECTOR AND OTHERS AND THERE'SA 929 00:39:05,961 --> 00:39:08,864 MODEL AND HOPE THE FUNDING IS 930 00:39:08,864 --> 00:39:09,464 MOVING TOWARDS THE BEST 931 00:39:09,464 --> 00:39:16,071 PRACTICES AND STANDARDS. 932 00:39:16,071 --> 00:39:16,371 >> RACHEL. 933 00:39:16,371 --> 00:39:21,009 >> TO GIVE GERRY A THANKS FOR 934 00:39:21,009 --> 00:39:22,010 THE NOTE OF CONFIDENCE AND HHS 935 00:39:22,010 --> 00:39:24,213 IN ALLOWING ME TO TAKE THIS 936 00:39:24,213 --> 00:39:24,546 POSITION. 937 00:39:24,546 --> 00:39:27,216 TO THE POINT THAT WAS JUST MADE 938 00:39:27,216 --> 00:39:29,718 ABOUT THE PRIVATE SECTOR, I JUST 939 00:39:29,718 --> 00:39:31,353 CAME FROM A MEETING OF PEOPLE 940 00:39:31,353 --> 00:39:32,988 TALKING ABOUT THE APPLICATIONS 941 00:39:32,988 --> 00:39:36,191 OF A.I. IN HEALTH AND THE ROLE 942 00:39:36,191 --> 00:39:38,460 THE FEDERAL GOVERNMENT IN 943 00:39:38,460 --> 00:39:40,596 OVERSEEING THOSE AND SEEING WHAT 944 00:39:40,596 --> 00:39:41,930 ACTIVITIES ARE UNDERWAY. 945 00:39:41,930 --> 00:39:42,798 IT'S CLEAR THAT THE PRIVATE 946 00:39:42,798 --> 00:39:44,800 SECTOR DOES HAVE TO BE ENGAGED 947 00:39:44,800 --> 00:39:45,200 IN THIS. 948 00:39:45,200 --> 00:39:47,836 OUR MANDATE OF COURSE AS JUST 949 00:39:47,836 --> 00:39:50,606 OUTLINED BY DR. TABAK IS BROAD 950 00:39:50,606 --> 00:39:53,041 AND INCLUDES THAT BUT WE ARE 951 00:39:53,041 --> 00:39:54,943 REALLY FOCUSSING ON THE ELEMENTS 952 00:39:54,943 --> 00:39:58,247 OF BIO SECURITY IN THIS AND 953 00:39:58,247 --> 00:39:59,581 UNDERSTANDING WHAT THE RISK AND 954 00:39:59,581 --> 00:40:01,817 POTENTIAL ADVANTAGES ARE TO THE 955 00:40:01,817 --> 00:40:03,118 APPLICATIONS OF A.I. IN RESEARCH 956 00:40:03,118 --> 00:40:05,587 VERY BROADLY DEFINED. 957 00:40:05,587 --> 00:40:08,624 SO I JUST WANT TO NOTE THAT AND 958 00:40:08,624 --> 00:40:10,459 SAY THAT THE SUPPORT AND 959 00:40:10,459 --> 00:40:16,665 INFORMATION THAT'S BEEN PROVIDED 960 00:40:16,665 --> 00:40:22,437 ALREADY BY THE PEOPLE AT NASF 961 00:40:22,437 --> 00:40:26,275 WHICH ARE INCREDIBLE AND IN 962 00:40:26,275 --> 00:40:27,509 FOLLOWING GERRY'S LARGE FOOT 963 00:40:27,509 --> 00:40:29,444 STEPS LEADING THE CHARGE IN WHO 964 00:40:29,444 --> 00:40:30,646 COMPLEX CHARGES AND HOW THEY CAN 965 00:40:30,646 --> 00:40:33,215 BE CARRIED OUT BUT I HAVE FULL 966 00:40:33,215 --> 00:40:34,783 CONFIDENCE IN THE MEMBERS OF THE 967 00:40:34,783 --> 00:40:37,319 NSABB TO ADDRESS THOSE AS WAS 968 00:40:37,319 --> 00:40:38,720 POINT THE OUT THEY'RE VERY BUSY 969 00:40:38,720 --> 00:40:40,155 PEOPLE BUT IN ROLES I THINK THAT 970 00:40:40,155 --> 00:40:43,025 WILL ALLOW US TO CONTRIBUTE IN A 971 00:40:43,025 --> 00:40:47,229 SUBSTANTIAL WAY IN THIS TASK. 972 00:40:47,229 --> 00:40:49,531 >> RACHEL, I TOTALLY AGREE. 973 00:40:49,531 --> 00:40:51,099 I HAVE FULL CONFIDENCE. 974 00:40:51,099 --> 00:40:52,234 IT'S AN AGGRESSIVE TASK BUT IT'S 975 00:40:52,234 --> 00:40:57,205 NEED ED AND TIMELY AND HAVE 976 00:40:57,205 --> 00:40:58,607 CONFIDENCE IN YOUR LEADERSHIP 977 00:40:58,607 --> 00:41:00,275 RAND EXPERTISE TO LEAD THE GROUP 978 00:41:00,275 --> 00:41:01,343 THROUGH THIS SO THANK YOU FOR 979 00:41:01,343 --> 00:41:11,887 TAKING ON THIS LEADERSHIP ROLE. 980 00:41:12,120 --> 00:41:14,523 >> ANY OTHER QUESTIONS? 981 00:41:14,523 --> 00:41:24,900 >> NO HANDS RIGHT NOW. 982 00:41:29,471 --> 00:41:31,239 >> I WANT TO ASK THE MEMBER TO 983 00:41:31,239 --> 00:41:33,041 THINK ABOUT WHO DO YOU WANT TO 984 00:41:33,041 --> 00:41:34,609 HEAR FROM AND WHO DO YOU HAVE TO 985 00:41:34,609 --> 00:41:37,079 HEAR FROM AND THAT WILL BE 986 00:41:37,079 --> 00:41:39,047 SOMETHING THAT WILL BE SOME OF 987 00:41:39,047 --> 00:41:40,582 YOUR FIRST CONVERSATIONS LOOKING 988 00:41:40,582 --> 00:41:42,484 BACK TO WHERE WE BEGAN THE 989 00:41:42,484 --> 00:41:44,186 CHARGE FOR OUR 2023 REPORT THAT 990 00:41:44,186 --> 00:41:45,988 WAS ONE OF THIS FIRST THINGS I 991 00:41:45,988 --> 00:41:49,958 RECALL DOING IS THINKING ABOUT 992 00:41:49,958 --> 00:41:51,893 WHO WE MUST HEAR FROM AND HOW TO 993 00:41:51,893 --> 00:41:52,694 DO THAT. 994 00:41:52,694 --> 00:41:55,197 AND YOU WILL AS MEMBERS WILL 995 00:41:55,197 --> 00:41:57,332 HAVE A WAY TO MOVE FORWARD IN 996 00:41:57,332 --> 00:41:58,200 THE AGGRESSIVE TIME LINE AND 997 00:41:58,200 --> 00:42:01,303 NEED TO HIT THE GROUND GROUND 998 00:42:01,303 --> 00:42:09,077 RUNNING IN JANUARY 2025. 999 00:42:09,077 --> 00:42:11,780 >> ANY OTHER FINAL THOUGHTS 1000 00:42:11,780 --> 00:42:12,948 BEFORE WE COME TO THE CLOSING OF 1001 00:42:12,948 --> 00:42:14,282 THE MEETING? 1002 00:42:14,282 --> 00:42:15,684 ANY OTHER FINAL HAND OR COMMENTS 1003 00:42:15,684 --> 00:42:19,988 FROM MEMBERS? 1004 00:42:19,988 --> 00:42:21,556 CARI, AM I MISSING ANYTHING 1005 00:42:21,556 --> 00:42:22,858 BEFORE WE GO TO CLOSING 1006 00:42:22,858 --> 00:42:23,125 COMMENTS? 1007 00:42:23,125 --> 00:42:28,764 >> NOTHING FROM ME. 1008 00:42:28,764 --> 00:42:30,665 DR. TABAK, DR. JORGENSON? 1009 00:42:30,665 --> 00:42:35,737 >> NO, THANK YOU. 1010 00:42:35,737 --> 00:42:38,173 >> RACHEL? 1011 00:42:38,173 --> 00:42:38,673 WELL -- 1012 00:42:38,673 --> 00:42:42,210 >> LOOKING FORWARD TO THIS 1013 00:42:42,210 --> 00:42:43,845 AGGRESSIVE TIMETABLE AND I THINK 1014 00:42:43,845 --> 00:42:48,417 THE INFORMATION THAT WE'VE BEEN 1015 00:42:48,417 --> 00:42:52,087 GIVEN IS VERY WELL SUBSTANTIATED 1016 00:42:52,087 --> 00:42:54,122 WITH WHICH THE SCIENCE AND 1017 00:42:54,122 --> 00:42:55,357 TECHNOLOGY IS MOVING FORWARD AND 1018 00:42:55,357 --> 00:42:58,293 THE NEED FOR US TO MOVE FORWARD. 1019 00:42:58,293 --> 00:42:59,728 >> WITH THAT I'M GOING TO GO 1020 00:42:59,728 --> 00:43:05,167 AHEAD AND BEGIN TO WRAP UP THE 1021 00:43:05,167 --> 00:43:05,400 MEETING. 1022 00:43:05,400 --> 00:43:06,701 SO, AS WE'VE ALL HEARD TODAY THE 1023 00:43:06,701 --> 00:43:09,037 NSABB IS A VERY CRITICAL VOICE 1024 00:43:09,037 --> 00:43:12,407 IN THESE CONVERSATIONS AND THE 1025 00:43:12,407 --> 00:43:15,010 INPUT WE'VE DONE HAS BEEN PUT TO 1026 00:43:15,010 --> 00:43:17,079 GOOD USE AND HAS INFORMED 1027 00:43:17,079 --> 00:43:18,280 U.S. GOVERNMENT POLICIES IN 1028 00:43:18,280 --> 00:43:20,215 THINKING ON THIS AND I NOTICED 1029 00:43:20,215 --> 00:43:21,917 THE NEXT CHARGE YOU'LL BE 1030 00:43:21,917 --> 00:43:25,720 WORKING ON WILL DO THE SAME 1031 00:43:25,720 --> 00:43:25,921 THING. 1032 00:43:25,921 --> 00:43:28,090 AS WE HEARD ACTUALLY OUR LAST 1033 00:43:28,090 --> 00:43:30,092 WORK THAT CONTRIBUTED DIRECTLY 1034 00:43:30,092 --> 00:43:31,159 TO THE DIRK PAP POLICY AND 1035 00:43:31,159 --> 00:43:33,628 CONTRIBUTING TO ALL THE 1036 00:43:33,628 --> 00:43:35,363 CONVERSATIONS RIGHT NOW. 1037 00:43:35,363 --> 00:43:36,865 SO WITH THAT BEFORE WE CLOSE I 1038 00:43:36,865 --> 00:43:39,167 WANT TO THANK EVERYBODY FOR 1039 00:43:39,167 --> 00:43:40,735 PARTICIPATING TODAY AND THOSE 1040 00:43:40,735 --> 00:43:43,572 WHO HAVE JOINED US ON WEBCAST. 1041 00:43:43,572 --> 00:43:46,141 I REALLY WANT TO PROVIDE NOW ONE 1042 00:43:46,141 --> 00:43:48,143 FINAL THANK YOU TO EVERYONE. 1043 00:43:48,143 --> 00:43:49,111 TO ALL MY COLLEAGUES AND 1044 00:43:49,111 --> 00:43:51,480 COLLEAGUE MEMBERS WHO SERVED ON 1045 00:43:51,480 --> 00:43:53,782 THE NSABB WITH ME DURING MY 1046 00:43:53,782 --> 00:43:55,817 TENURE, I ESPECIALLY WANT TO 1047 00:43:55,817 --> 00:43:57,552 THANK THE NIH STAFF AND OSP FOR 1048 00:43:57,552 --> 00:43:59,888 ALL THE SUPPORT YOU DID AND IT 1049 00:43:59,888 --> 00:44:02,157 WAS SUCH PROFESSIONAL DEDICATED 1050 00:44:02,157 --> 00:44:03,458 SERVICE TO THE BOARD. 1051 00:44:03,458 --> 00:44:04,159 IT WAS WONDERFUL. 1052 00:44:04,159 --> 00:44:07,329 IT REMINDED ME OF MY PREVIOUS 1053 00:44:07,329 --> 00:44:08,363 TIME IN GOVERNMENT SERVICE AND 1054 00:44:08,363 --> 00:44:10,665 WHY I USED TO LOVE WORKING IN 1055 00:44:10,665 --> 00:44:12,200 GOVERNMENT SERVICE. 1056 00:44:12,200 --> 00:44:14,436 SOME OF THE GREAT PEOPLE YOU GOT 1057 00:44:14,436 --> 00:44:16,538 THE CHANCE TO WORK WITH. 1058 00:44:16,538 --> 00:44:19,674 CARI AND KEVIN AND OTHERS AND 1059 00:44:19,674 --> 00:44:22,611 DR. TABAK AND DR. JORGENSON, 1060 00:44:22,611 --> 00:44:23,378 THANK YOU. 1061 00:44:23,378 --> 00:44:26,481 AND THANK THE SUPPORT FROM NIH, 1062 00:44:26,481 --> 00:44:29,050 HHS, AND OTHERS FOR ALLOWING ME 1063 00:44:29,050 --> 00:44:30,285 TO SERVE ON NSABB AND SERVE AS 1064 00:44:30,285 --> 00:44:30,485 CHAIR. 1065 00:44:30,485 --> 00:44:33,121 I WANT TO THANK ALL THE OTHER 1066 00:44:33,121 --> 00:44:37,792 NSABB MEMBERS WHO SERVED AND 1067 00:44:37,792 --> 00:44:40,195 CAME BEFORE ME AND NSABB WAS 1068 00:44:40,195 --> 00:44:41,830 ESTABLISHED IN 2005, IS THAT 1069 00:44:41,830 --> 00:44:42,197 CORRECT? 1070 00:44:42,197 --> 00:44:44,666 I THINK IT WAS 2005 BUT THE NEW 1071 00:44:44,666 --> 00:44:47,002 MEMBERS COMING IN ON THE BOARD 1072 00:44:47,002 --> 00:44:48,470 WILL QUICKLY LEARN THAT THERE'S 1073 00:44:48,470 --> 00:44:50,238 A FOUNDATION OF KNOWLEDGE THAT 1074 00:44:50,238 --> 00:44:52,307 WE CONTINUE TO BUILD UPON AND 1075 00:44:52,307 --> 00:44:54,609 THE NEW CHARGE WE'RE GOING TO BE 1076 00:44:54,609 --> 00:44:56,111 BUILDING UPON THE WORK WE DID 1077 00:44:56,111 --> 00:44:57,579 OVER THE LAST FOUR YEARS. 1078 00:44:57,579 --> 00:44:59,481 ANYWAY, I WANT TO THANK 1079 00:44:59,481 --> 00:45:00,682 EVERYBODY WHO PREVIOUSLY SERVED 1080 00:45:00,682 --> 00:45:01,449 ON NSABB TOO. 1081 00:45:01,449 --> 00:45:03,351 SO WITH THAT, THE MEETING IS 1082 00:45:03,351 --> 00:45:03,618 ADJOURNED. 1083 00:45:03,618 --> 00:45:03,885 THANK YOU. 1084 00:45:03,885 --> 00:45:06,154